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Summary 
Human amyloid precursor protein (APP) belongs to a gene family that codes for type I 
trans-membrane proteins in different species, including fruit flies, roundworms and mice. 
Amyloid Precursor-like Protein1 and 2 (APLP1 and APLP2) are the two other mammalian 
members of this gene family. Like APP, APLP1 and APLP2 are transmembrane proteins 
with a large extracellular N-terminal domain and short cytoplasmic C-terminal fragment. 
Another common feature of APP/APLPs is their processing by enzymatic activities called 
secretases. Unlike APLP1 and APLP2, APP processing can generate amyloid beta peptides 
(Abeta) which precipitate in the brain of Alzheimer patients. Therefore, it is not surprising 
that APP has been extensively studied in the context of Alzheimer disease. 
Nevertheless, APP and its two paralogues, APLP1 and APLP2, are expressed in early 
stages of brain development suggesting a physiological function for these proteins in early 
neurodevelopment. However, genetic knock-out and shRNA studies have led to 
contradictory conclusions about their role during embryonic brain development. In 
particular, down-regulation of APP in precursors and neurons of the developing cortex in 
vivo blocks the migration of neurons towards the cortical plate, while conversely, neurons 
in an APP/APLP1/APLP2 triple knock-out (ko) mouse over-migrate and accumulate 
ectopically in the marginal zone. The yet unexplained discrepancy between the over-
migration effects in the triple ko and the blocked migration in the case of APP down-
regulation shows that the role of the APP family members in the course of cortical 
development is still unclear. 
We hypothesized that APP and APLPs might regulate distinct processes in the developing 
cortex based on the differential mRNA expression profiles for APP gene family members. 
During cortical development: APP is found in the cortical plate (CP) and ventricular zone 
(VZ), APLP2 in the VZ and subventricular zone (SVZ) and APLP1 in the CP only. The 
restriction of APLP2 expression to the proliferative zones (VZ/SVZ) of the developing 
cortex suggests a specific function for APLP2 in the development and specification of 
cortical progenitors. Therefore we focused our attention on the involvement of APLP2 in 
cortical development. 
To this end, we interfered with APLP2 expression in developing cortices of wildtype (wt) 
mice using in utero electroporation. APLP2 down-regulation in wt cortices did not change 
cortical positioning of neurons. Next, we down-regulated APLP2 expression in 
APP/APLP1 dko mice reasoning that partial overlapping functions with APP and APLP1 
might compensate for the absence of APLP2. While APP/APLP1 dko neurons migrated 
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normally to the cortical plate, similar to their wt counterparts, further APLP2 down-
regulation in APP/APLP1 dko cells blocked cells predominantly in the proliferative zones 
of the developing cortex, leading to altered cortical positioning. We will use the term 
―triple ko‖ in the rest of the thesis to refer to these APP/APLP1dko cells that express 
APLP2shRNA. Our analysis shows that arrested cells remain undifferentiated as 
demonstrated by the continuous expression of progenitor and mitotic markers. We find that 
the morphology of ―APP/APLP1/APLP2 triple ko‖ migrating neurons and ―triple ko‖ 
radial glia fibers, a major substrate for neuronal migration, is normal. Furthermore, the 
migration of triple ko neurons in vitro seems not affected. Further investigation of the 
properties of neuronal progenitors showed delayed neuronal differentiation and decreased 
cell cycle exit of the triple deficient cells.  
In summary, our data reveal a novel function of APLP2 in the regulation of proper cell 
cycle exit of neuronal progenitors.  
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Samenvatting 
Humaan amyloid voorlopereiwit (Amyloid Precursor Protein of APP) behoort tot een 
genfamilie die codeert voor type I transmembranaire proteïnen in verschillende diersoorten, 
waaronder fruitvliegen, rondwormen en muizen. Amyloid Precursor-like Proteïne 1 en 2 
(APLP1 en APLP2) zijn de 2 andere leden van deze genfamilie in zoogdieren. Zoals APP 
zijn APLP1 en APLP2 transmembranaire proteïnen met een groot extracellulair N-
terminaal domein en een kort cytoplasmatisch C-terminaal fragment. Een andere 
gemeenschappelijke eigenschap van APP/APLPs is hun klieving door enzymen, de 
secretasen. Anders dan APLP1 en APLP2, kan het verwerken van APP amyloïd beta 
peptiden (Abeta) genereren die neerslaan in de hersenen van Alzheimer patiënten. Daarom 
is het niet verrassend dat APP uitgebreid bestudeerd is in de context van de ziekte van 
Alzheimer. 
 APP en zijn 2 paralogen, APLP1 en APLP2, komen al tot expressie in vroege stadia van 
hersenontwikkeling, wat een fysiologische functie voor deze proteïnen suggereert in prille 
neuronale ontwikkeling. Genetische knock-out en shRNA studies hebben echter geleid tot 
contradictorische conclusies betreffende hun rol tijdens embryonale hersenontwikkeling. 
Meer bepaald down-regulatie van APP in voorlopers en neuronen van de ontwikkelende 
cortex in vivo blokkeert de migratie van neuronen naar de corticale plaat, terwijl 
omgekeerd, neuronen in een App/Aplp1/Aplp2 drievoudige knock-out (ko) muis over-
migreren en ectopisch accumuleren in de marginale zone. De tot nog toe onverklaarde 
discrepantie tussen de over-migratie effecten in de drievoudige ko en de geblokkeerde 
migratie in het geval van App down-regulatie toont dat de rol van APP familieleden in het 
verloop van corticale ontwikkeling nog onduidelijk is. 
We veronderstelden dat App en Aplps verschillende processen in de zich ontwikkelende 
cortex zouden kunnen regelen, gebaseerd op de verschillende mRNA expressie profielen 
voor leden van de APP genfamilie. Tijdens corticale ontwikkeling komt App tot expressie 
in de corticale plaat (CP) en de ventriculaire zone (VZ), Aplp2 in de VZ en 
subventriculaire zone (SVZ) en Aplp1 enkel in de CP. De beperking van Aplp2 expressie 
tot de proliferatieve zones (VZ/SVZ) van de ontwikkelende cortex suggereert een 
specifieke functie voor APLP2 in de ontwikkeling en specificatie van corticale voorlopers. 
Daarom hebben we onze aandacht gericht op de betrokkenheid van Aplp2 in corticale 
ontwikkeling. 
Hiertoe interfereerden we met Aplp2 expressie in de ontwikkelende cortex van wildtype 
(wt) muizen door middel van in utero elektroporatie. Onderdrukken van Aplp2 expressie in 
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wt cortex veranderde de corticale positionering van neuronen niet. Vervolgens 
onderdrukten  we Aplp2 expressie in App/Aplp1 dubbele ko muizen, met de 
achterliggende gedachte dat  gedeeltelijk overlappende functies van App en Aplp1 zouden 
kunnen compenseren voor de afwezigheid van Aplp2. Terwijl App/Aplp1 dko neuronen 
normaal migreren naar de corticale plaat, vergelijkbaar met hun wt tegenhangers, leidt 
verdere onderdrukking  van Aplp2 in App/Aplp1 dko cellen tot stopzetting van hun 
migratie hoofdzakelijk in de proliferatieve zones van de ontwikkelende cortex. Dit 
veroorzaakt  verandering van hun corticale positionering. Onze analyse toont aan dat 
afgestopte cellen ongedifferentieerd blijven zoals aangetoond door de continue expressie 
van voorloper en mitotische markers. We observeerden dat de morfologie van 
"App/Aplp1/Aplp2" drievoudige ko‖ migrerende neuronen en ―drievoudige ko‖ radiale 
glia-vezels, een belangrijk substraat voor neuronale migratie, normaal is. Bovendien lijkt 
de migratie van drievoudige ko neuronen in vitro niet aangetast. Verder onderzoek van de 
eigenschappen van neuronale voorlopers toont vertraagde neuronale differentiatie en 
verlaten de cel cyclus van de drievoudig deficiënte cellen minder. 
Samengevat brengen onze data een nieuwe functie van Aplp2 in de regulatie van correcte 
cel cyclus uitgang van neuronale voorlopers aan het licht. 
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Chapter I: Introduction  
Large parts of this chapter have been published in: 
S. Ali M. Shariati and Bart De Strooper, Redundancy and divergence in the amyloid 
precursor protein family, FEBS letters, Volume 587, Issue 13 , Pages 2036-2045,  2013.  
In 1987, Amyloid Precursor Protein (APP) gene was identified when different research 
groups were searching for a putative precursor of the Abeta peptide. Amyloid beta peptide 
was known to be a major component of the amyloid plaques that are found in brains of 
people with Alzheimer‘s disease (AD) (Goldgaber, Lerman et al. 1987; Kang, Lemaire et 
al. 1987; Tanzi, Gusella et al. 1987). In the following years, homologues of APP were 
identified in human, mouse, as well as in Drosophila (Rosen, Martin-Morris et al. 1989; 
Coulson, Paliga et al. 2000). Although human APP was originally identified and named 
because of its link to AD, the conservation of the APP genes in the genomes suggests an 
advantage for the organisms. Therefore, parallel to the effort in understanding the 
pathogenic role of the human APP in AD, several groups are investigating the 
physiological function of APP proteins with a particular focus on the nervous system. The 
work presented in this thesis also aim to address the role of APP proteins in the mouse 
nervous system. 
APP is the most-studied member of the APP protein family. I start the introduction by 
explaining the features of subdomains of APP as a well-studied member of the family. 
However, the APP gene family in mammals has two other members named APLP1 and 
APLP2 (amyloid precursor-like protein). The interaction between the three genes and 
potential overlapping functions are complicating factors in analyzing the function of APP 
proteins in loss of function studies. Therefore, explaining evolution of APP gene family 
would help to understand the common and distinct features of APP proteins among 
different species.  
One of the common features of the APP proteins from different species is their proteolytic 
processing by membrane proteases called secretases. Secretases cleave APP proteins into 
different fragments with functions potentially distinct from the full-length APP molecule 
suggesting different mechanism of action for APP proteins. On the other hand, the 
expression pattern and interaction network of APP and APLPs seems to be distinct for each 
member. Insight from knock-out models of APP genes in different species shows both 
distinct and overlapping phenotypes for each member. In the case of murine cortical 
development, deficiency of App proteins (In the text, mouse proteins are indicated with 
first capital letter followed by lower cases and human proteins are all capital letters. Genes 
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follow the same rule but are italicized.) leads to apparently opposite outcomes in neuronal 
migration. We hypothesized that different members of App proteins can regulate distinct 
processes during cortical development. In particular, we focused on the role of Aplp2 in the 
regulation of neural stem cell differentiation. 
 
1.1 Amyloid Precursor Protein domain structure and function 
 
APP is a type I transmembrane protein that has a large N-terminal domain and a short C-
terminal fragment. The N-terminal domain of APP is divided into two regions: so called 
E1- and E2- regions together with two unstructured parts called the acidic and linker 
regions (Fig. 1). The N-terminal-part of APP starts with the E1 domain which encompasses 
Growth-factor like domain (GFLD) and a Copper binding domain (CuBD). The crystal 
structure of GFLD showed that this domain is composed of 9 β stands and 1 α helix which 
together form a globular compact domain (Rossjohn, Cappai et al. 1999). There are three 
disulfide bonds in this domains; Cys38-Cys62, Cys37-Cys117, Cys98-Cys105. The Cys98-
Cys105 disulfide bond is at the center of a highly charged surface between amino acid 96-
110 patch (Rossjohn, Cappai et al. 1999). This sequence was previously shown to form a 
positively charged surface for heparin binding (negatively charged polysaccharide 
glycosaminoglycan) that regulates neurite outgrowth in primary neurons (Small, Nurcombe 
et al. 1994). In fact, combination of APP and heparan sulfate proteoglycan significantly 
potentiated the neurite outgrowth in primary neurons in vitro, whereas separately they did 
not (Small, Nurcombe et al. 1994). This is particularly interesting because it has been 
shown that the E1 domain of APP forms dimers upon binding to heparin (Dahms, Hoefgen 
et al. 2010) suggesting that the dimerization of APP can lead to the generation of a binding 
site for signaling factors that modulate neurite outgrowth. Alternatively, one can 
hypothesize that secreted GFLD binds to heparan sulfate proteoglycan in ligand-receptor 
mode of action, a mechanism that separates the function of soluble APP and membrane 
anchored APP. However, the functional importance of this interaction and the definitive 
putative receptor for soluble APP remain unidentified. The GFLD is followed by the CuBD 
which has 3 β strands and 1 α helix which are connected by two disulfide bonds (Barnham, 
McKinstry et al. 2003; Kong, Adams et al. 2007). His147, His151 and Tyr168 are the 
residues that participate in copper binding by the CuBD (Barnham, McKinstry et al. 2003; 
Kong, Adams et al. 2007). These three residues are conserved in human APLP2 and mouse 
Aplp2 suggesting a possible conservation of this copper binding between APP and APLP2. 
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This might provide neurons with a defense system against copper toxicity caused by high 
concentration of copper. Supporting this hypothesis, App knock-out (ko) neurons are more 
sensitive to neuronal death caused by copper toxicity. Unlike App ko neurons, Aplp2 ko 
neurons behave similar to the wt in response to high concentration of copper suggesting 
that the App protein regulates indeed copper homeostasis (White, Multhaup et al. 1999). 
The GFLD and CuBD are linked by an interdomain region that constitutes an interface for 
the interaction of the two subdomains. Many of the residues that participate in this 
interaction are conserved between APP and APLP2 but not APLP1 (Dahms, Hoefgen et al. 
2010).  In addition, Kaden et al showed that a synthetic peptide corresponding to the wt 
sequence of this loop region reduced dimerization of APP in vitro. This reduction was 
accompanied by a selective decreased β-cleavage of APP suggesting a role for dimerization 
in the regulation of APP processing (Kaden, Munter et al. 2008). In a cellular context, APP 
and APLPs promote cellular adhesion by dimerization in COS7 (Fibroblast-like Kidney 
Cells from monkey) (Soba, Eggert et al. 2005). Soba et al showed that APP and APLPs can 
form homo- and heteromeric complexes which are dependent on the E1 domain. These 
interactions at the cell surface increased cell clustering, supporting the intercellular 
adhesion role for APP and APLPs. Using a cell aggregation assay, App ko mouse 
embryonic fibroblasts formed similar number of aggregates when compared to wt. 
However, double ko of App/Aplp1 or single Aplp2 ko fibroblasts reduced the number of 
aggregates raising the possibility that App/Aplp1 and Aplp2 do not equally contribute to 
the fibroblasts adhesion and Aplp2 plays a more significant role (Soba, Eggert et al. 2005).  
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Figure 1. Schematic illustration of APP subdomains  
Schematic representation of subdomains of APP. large extracellular domain of APP can be 
divided into E1 and E2 regions which are two structural subdomains of the APP n-terminal 
linked by a stretch of acidic amino acid. The E1 region contains growth-factor like domain 
(GFLD) and a copper binding domain (CuBD). The E1 and the E2 regions are linked by a short 
stretch of acidic amino acids. Two important features of E2 region are Kunitz protease inhibitor 
(KPI) and RERMS sequence which may contribute to APP signaling. APP is cleaved next to 
Abeta region (in red) by β secretase activity (red arrow) leading to production of soluble APPβ. 
Next APP stub is further processed by γ secretase activity (orange arrows) leading to production 
of Aβ and APP intracellular domain (AICD). Alternatively, the cleavage of APP can start with α 
secretase activity (green arrow) which will generate soluble APPα, and P3 and AICD by γ 
secretase activity. The short C-Terminal of APP is where APP binds to its intracellular 
interactors which are further discussed in the text. Two well-studied phosphorylation sites are 
also indicated and further discussed in the text.  
 
An unstructured acidic region links the E1 with the E2 domain. Earlier studies showed that 
a distinct sequence of five amino acid residues known as the RERMS sequence resides in 
E2 region which possibly contributes to the growth promoting properties of APP such as 
fibroblast proliferation, neuronal survival and neurite outgrowth (Fig.1) (Ninomiya, Roch 
et al. 1993; Jin, Ninomiya et al. 1994; Ninomiya, Roch et al. 1994; Yamamoto, Miyoshi et 
al. 1994). The crystal structure of E2 domain revealed 6 α helices forming a coiled-coiled 
structure. The overall structure of E2 domain of APLP1 is similar to APP meaning it can 
form dimers and bind to heparin (Lee, Xue et al. 2011; Xue, Lee et al. 2011). Analysis of 
the crystal structure showed that E2 domain dimers can form in anti-parallel orientation. 
Dimerization of the E2 domain creates a groove of positively charged amino acids that is a 
binding site for heparin. Unlike the heparin binding site in the E1 domains, the heparin 
binding residues in the E2 domain are conserved (Wang and Ha 2004). Interestingly, 
heparin binding induced dimerization of E2 domains (Wang and Ha 2004). Therefore, it is 
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very likely that these two heparin binding domains regulate the dimerization and binding 
properties of full-length and soluble APP and APLPs. A third region that can mediate APP 
dimerization is located at the boundary of transmembrane and juxtamembrane domain of 
APP where three GxxxG motifs are located. These motifs are situated close to the cleavage 
sites of APP and therefore might regulate APP processing and function (Kienlen-Campard, 
Tasiaux et al. 2008; Sato, Tang et al. 2009; Khalifa, Van Hees et al. 2010). Indeed, this 
GxxxG motif was shown to be required for Abeta production but not APP Intracellular 
Domain (AICD) release which is the product of γ-cleavage of the APP C-terminal 
fragment. Changing the glycine pair to leucine significantly decreased the production of 
Abeta in CHO cells (Kienlen-Campard, Tasiaux et al. 2008). Overall, these data suggest 
that APP has adhesion properties and may be involved in cell-cell or cell-substrate 
adhesion and (or) signaling at the surface of the cell (Reinhard, Hebert et al. 2005). 
In analogy with Notch signaling, the processing of the APP C-terminal fragment can 
release AICD which is postulated to form a multi-meric complex with transcriptional 
activity of cytoplasmic fragment of the APP (Cao and Südhof 2001; Cupers, Orlans et al. 
2001). Initially, when intracellular domain of APP was fused to Gal4 transcription factor, 
this fusion protein alone did not activate the Gal4-dependent reporter. Searching for 
possible interactors that can boost AICD mediated transcription, over-expression of Fe65 
turned out to be a potent stimulator of transcription. Finally, the authors proposed that 
AICD-Fe65 bind to Tip60, a histone acetyltransferase, to form a nuclear ternary complex 
that directly regulates transcription (Cao and Südhof 2001). Later, it was shown that 
cytoplasmic fragment of the APP has a short half life (less than 5 min) and is partially 
distributed to the nucleus (Cupers, Orlans et al. 2001). More recently, a similar Gal4 assay 
showed that transcriptional activity of AICD depends on Med12 which is a RNA 
polymerase II regulator, suggesting a direct link between AICD of APP and the 
transcriptional machinery. In addition, a physical interaction between AICD and Med12 
supported the role of AICD in gene regulation (Xu, Zhou et al. 2011). Until now, many 
endogenous AICD target genes such as APP itself, BACE1, GSK-3β, KAI1 and Neprilysin 
were reported using exogenous expression of the AICD (Nalivaeva and Turner 2013). In 
contrast, complete deficiency of APP/APLPs did not influence the expression of the 
proposed target genes such as APP, KAI1, GSK-3β and Neprilysin, suggesting that 
intracellular domains of APP/APLPs are not potently involved in gene regulation at basal 
level (Hebert, Serneels et al. 2006). Therefore, the reports are conflicting on the 
transcriptional role and the identity of AICD target genes (Hebert, Serneels et al. 2006; 
Waldron, Isbert et al. 2008; Huysseune, Kienlen-Campard et al. 2009; Xu, Zhou et al. 
2011).   
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Currently, the experimental data are not available to compare the structure of the APLP2 
with APP and APLP1. As it was discussed, the crystal structure of the E2 domain of 
APLP1 is very similar to APP but the crystal structure of APLP2 or its subdomains are not 
available. At the level of protein sequence each one of these protein has unique motifs 
which potentially can confer specific structural features to each member. For example, the 
N-terminal of APLP2 homologues contains a unique GTGFAVAE motif with unknown 
function (Fig. 2). On the contrary, the C-terminal YENPTY motif is universally conserved 
in all members of the APP protein family, providing a common site for intracellular 
interactors of APP and APLPs (Fig.1,2). Experimental structural data for APLP2 will be 
valuable in understanding similarities and differences between APLP2 and APP or APLP1.   
 
Figure 2. Examples of conserved and diverged motifs in the APP protein family 
Alignment of APP protein family shows that the YENPTY motif at the c-terminal of this gene 
family is a universally conserved motif.  The numbers above the figures indicate the alignment 
position of amino acids from N terminal to C terminal.  
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1.2 Evolution of the Amyloid Precursor Protein Family 
 
Genes encoding for the APP protein family have experienced several twists and turns 
during evolution. APP-like proteins have not been identified in prokaryotes, yeasts and 
plants (Fig. 3). The simplest and earliest branches of the evolutionary tree in which APP-
like genes have been identified contain insects such as the fruit fly (D.melanogaster) and 
roundworms (C.elegans) each carrying one gene encoding for an APP-like protein. It is 
intriguing that APP-like proteins first emerge in Bilaterians with an early nervous system 
with functional synapses (Emes, Pocklington et al. 2008; Ryan and Grant 2009). Indeed, 
the extracellular domains of APP molecules have cell adhesion properties and can promote 
cell-cell adhesion (Soba, Eggert et al. 2005). Such intercellular interaction is important in 
early evolution for the generation of the synaptic junction (Emes, Pocklington et al. 2008; 
Emes and Grant 2012). Strikingly, when over-expressed in HEK cells, APP can potently 
induce synaptogenesis in the contacting axon and this activity requires the extracellular 
domain as well as the intracellular part of APP. The latter associates with presynaptic 
molecules such as APP binding family A (APBA1) and Calcium/calmodulin-dependent 
serine protein kinase (CASK) (Wang, Wang et al. 2009). Interestingly, APP is required 
both at pre- and postsynaptic compartments to induce synaptogenesis (Wang, Wang et al. 
2009) which suggests that ancestral APP indeed might have evolved as a transmembrane 
protein responsible for homophilic interactions at the synaptic junction.  
Five nodes of duplications are observed in the phylogenetic tree of the APP protein family 
when using Ensemble comparative genomics tools (simplified in Figure 3). For example, 
zebra fish (D.rerio) has in total four genes encoding APP proteins: two homologues for the 
human APP gene (appa and appb) plus aplp1 and aplp2 (Fig. 3). Similar to fishes, 
amphibians (Xenopus laevis) carry four app genes in their genome but they have two 
homologues for the human APLP2 gene: aplp2a, aplp2b plus app and aplp1 (Fig. 3).  
Instead, birds (G. Gallus) have lost the APLP1 gene leaving them with APP and APLP2 
genes (Fig. 3). The paradoxical expansion and contraction of the APP family suggest that 
the duplications of the encoding genes have been the subject of highly selective 
evolutionary forces. The complicated trajectory of the evolution of the APP protein family 
ends with the three well-studied members in mammals: APP, APLP1 and APLP2 (Fig. 3) 
(Zheng and Koo 2011).  
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The evolutionary maintenance of a duplicated gene in the genome is influenced by the 
accumulation of genetic mutations affecting the function of the descendant duplicates. 
Three possible outcomes of duplication have been proposed: non-functionalization, 
neo(sub)functionalization or increased gene dosage (Innan and Kondrashov 2010). The 
non-functionalization scenario is the result of the accumulation of deleterious mutations 
leading to pseudogenization (Ohno 1970). In case of neo-functionalization, mutations 
confer new features to the duplicate which leads to the acquisition of new functions distinct 
from the ancestral ones (Force, Lynch et al. 1999). Subfunctionalization is a modified 
version of neofunctionalization in which the function of the ancestral gene becomes 
subdivided into subfunctions for each duplicate providing cells with proteins with more 
specialized functions (Innan and Kondrashov 2010). Finally without any functional 
innovation, duplication can provide cells with genetic robustness and redundancy by 
increasing the gene dosage for dosage sensitive genes (Conrad and Antonarakis 2007).  
Which model of gene duplication and evolution can be applied to the APP family? While 
the prevalent vision stresses the ―increased gene dosage‖, as I will discuss, more in depth 
interpretation of the data provide supporting evidence for neo or subfunctionalization of 
APP and APLPs as well. 
 
Figure 3 Simplified dendrogram of APP protein family 
The tree illustrates the important events in the evolution of APP gene family. The duplication 
and contraction nodes are color coded. The lengths of the lines are not proportional to the 
evolutionary distance of species. For details of APP protein family evolution see the text. Mya: 
million years ago.  
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1.3 Proteolytic processing of Amyloid Precursor Proteins 
 
APP undergoes proteolytic processing by enzymatic activities of the membranes secretases 
known as: α- secretase, β-secretase, and γ-secretase (Fig. 1). The first cleavage of APP by 
α-secretase or β-secretase releases soluble fragments and generates a membrane bound C-
terminal stub which is the substrate of γ-secretase. In case of APP this proteolytic 
processing is classified into two pathways: amyloidogenic when β-secretase cleaves first 
and non-amyloidogenic when α-secretase cleaves first. Only the former is linked to the 
pathogenesis of Alzheimer‘s disease because it produces Aβ which is the main component 
of amyloid plaques in the brain of patients. Interestingly, the proteases α-secretases, β-
secretases and γ-secretases are largely conserved during evolution, together with the 
overall processing of the membrane bound APP paralogues resulting in the release of APP 
ectodomain and intracellular domain.  
α-secretase cleaves APP between Lys16 and Leu17 of the Abeta domain (Fig. 1) (Esch, 
Keim et al. 1990). Cleavage of APP by α-secretase activity results in generation of a 
soluble fragment (sAPPα) and an 83 amino acid C-terminal fragment (C83). In mammals, 
different members of the ―A disintegrin and metalloprotease‖ (ADAM) family have been 
proposed as α-secretases (Deuss, Reiss et al. 2008; Vingtdeux and Marambaud 2012). 
Over-expression of ADAM 9, 10, 17 in cell culture system can change the processing of 
APP (Deuss, Reiss et al. 2008; Vingtdeux and Marambaud 2012). In neurons, there is 
convincing evidence that Adam10 carries out the constitutive processing of APP (Jorissen, 
Prox et al. 2010; Kuhn, Wang et al. 2010). The secretion of sAPPα is reduced by 90% in 
Adam10 deficient neurons, reflecting the importance of Adam10 for constitutive 
processing of App. ADAM10 and ADAM17 can both cleave APLP2, but, similar to APP, 
ADAM10 was found to be a constitutive α-secretase of APLP2 in neurons (Hogl, Kuhn et 
al. 2011). Although ADAM10 constitutively processes APP and APLP2, the induced 
processing of APP and APLP2 are regulated differently. Insulin growth factor 1(IGF1) has 
been shown to induce production of sAPPα, sAPLP1 and sAPLP2 (Adlerz, Holback et al. 
2007). Different α-secretases mediate the effect of IGF1 induced secretion of soluble 
fragments of APP and APLPs (Jacobsen, Adlerz et al. 2010). ADAM10 inhibition blocks 
the effect of IGF1 induced shedding of APP. Likewise, APLP1 processing was blocked 
after inhibition of ADAM10, whereas APLP2 ectodomain shedding was decreased only 
after down-regulation of ADAM17 (Jacobsen, Adlerz et al. 2010). Thus, it is likely that 
ADAM17 mediates the induced processing of APLP2, whereas ADAM10 mediates its 
constitutive processing.  
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In flies, a 130KD fragment that misses the carboxyl terminus of full-length APPL was 
identified and proposed as secreted form of APPL (Luo, Martin-Morris et al. 1990). 
Kuzbanian is the α-secretase like protease of flies which was identified because of its role 
in regulation of Notch signaling and neurogenesis (Rooke, Pan et al. 1996). More recently 
it was shown that  Kuzbanian can indeed also affect processing of flies‘ APPL (Carmine-
Simmen, Proctor et al. 2009). Therefore, despite small differences, α-secretase cleavages 
are conserved in APLPs family reflecting the physiological importance of this pathway. 
The physiological importance of this pathway is supported by data showing that sAppα can 
rescue the phenotypes of App deficient mice (Ring, Weyer et al. 2007). One can speculate 
that α-secretase generates soluble ectodomains of APP and APLPs which are active ligands 
for unknown receptors. It is not clear to what extent the biological activity of sAPPα, 
sAPLP1α and sAPLP2α are different or similar. One example of similar activity of 
different soluble fragments of APP family is neurite outgrowth. It has been shown that the 
conditioned medium of  CHO cells over-expressing APP, APLP1 or APLP2 similarly 
increase the length of the axons, suggesting similarity in the function of the soluble  
fragments of APP and APLPs in neurite outgrowth regulation (Young-Pearse, Chen et al. 
2008).  
β-secretase activity cleaves APP next to the N-terminal of the Abeta region generating 
sAPPβ and C99 (Fig. 1). Bace1 was identified as the major neuronal enzyme with β-
secretase activity and its deficiency blocks Abeta secretion in neurons (Vassar, Bennett et 
al. 1999; Cai, Wang et al. 2001). The decreased level of Abeta is accompanied by reduced 
levels of β-CTF (Pastorino, Ikin et al. 2004). It has been shown that BACE1 can alter 
processing of APLPs when over-expressed in HEK293 cells (Li and Südhof 2004). 
Consistent with these data, Bace1 deficiency significantly decreased  levels of soluble 
Aplp2 in the brain, whereas its over-expression had opposite effect (Pastorino, Ikin et al. 
2004). Parallel to decreased soluble Aplp2 in brain, the β-CTF of Aplp2 was diminished in 
Bace1 ko brain reflecting the overall similarity between App and Aplp2 β-cleavage 
(Pastorino, Ikin et al. 2004). However, more recently it was shown that Bace1 ko did not 
alter the CTF production of App or Aplps raising the possibility of compensatory 
mechanisms for β-secretase activity (Sala Frigerio, Fadeeva et al. 2010). β-secretase 
activity has also been described in flies and interestingly dBACE can process APPL into 
neurotoxic Aβ like peptide which can deposit in the brain similar to human APP (Carmine-
Simmen, Proctor et al. 2009). Therefore, similar to α-cleavage, β-secretase activity is 
conserved in the APP protein family. As it will be discussed later (section 1.3.3), the 16 
amino acid difference between sAPPα and sAPPβ have been proposed to contribute to 
striking differences in their functions, although this needs further mechanistic insight.  
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In addition to ectodomain shedding, β-secretase proteolytic processing of APP results in 
the release of Aβ with high propensity to aggregate. As this is a continuous process, the 
brain is constantly faced with the challenging task of controlling the concentration of Aβ 
below the aggregation threshold. The Aβ region is a novel feature of the APP paralogue 
and is not present as such in APLP1&2 or in the APP-homologues in C. elegans (APL1) 
and D. melanogaster (APPL). For example, recently it was shown that sequential cleavage 
of APLP1 by β- and γ-secretases generate APLP1 β peptides of 25, 27 and 28 amino acids 
(to be compared with Aβ from APP that contains 38,40 and 42 amino acids) which do not 
aggregate in the brains (Yanagida, Okochi et al. 2009). Interestingly, the analogy between 
the processing of APP and APLP1 has raised the possibility of using APLP1 derived p28 in 
the cerebrospinal fluid as a surrogate marker to detect altered activity of γ-secretases in 
individuals with an increased risk of Alzheimer ‘s disease (Yanagida, Okochi et al. 2009).  
γ-secretase cleaves C99 and C83 generated by β-cleavage and α-cleavage respectively (Fig. 
1). γ-secretase is a multi-subunit complex that is composed of : Presenilins (PS1 and PS2), 
anterior  pharynx-defective 1 (APH-1), Nicastrin, and Presenilin enhancer protein 2 (Pen2). 
A series of genetic and biochemical experiments showed that PS1 deficiency leads to the 
accumulation of APP CTF and blocks Abeta production in neurons showing that PS1 is the 
catalytic subunit of γ-secretase (De Strooper, Saftig et al. 1998; De Strooper, Annaert et al. 
1999; Wolfe, Xia et al. 1999). Likewise, the CTFs of APLP1 and APLP2 are also cleaved 
by γ-secretase. One of the early hints showing that APLPs are also processed by γ-secretase 
came from accumulation of APLP1 CTF in PS1 deficient neurons (Naruse, Thinakaran et 
al. 1998).  Further, CTFs of APLP1 and APLP2 were accidentally co-purified together with 
APP CTFs suggesting that APLP1 and APLP2 are also cleaved by γ-secretase (Gu, 
Misonou et al. 2001). Using both chemical inhibition and genetic deletion, there is now 
compelling evidence for γ-secretase processing of APLP1 and APLP2 (Walsh, Fadeeva et 
al. 2003; Eggert, Paliga et al. 2004; Yanagida, Okochi et al. 2009).    
Processing of C99 or C83 by γ-secretase generates AICD, in other words AICD is the 
common product of both amyloidogenic and non-amyloidogenic pathways. As it was 
discussed, this fragment can potentially translocate to nuclei to regulate gene expression. 
This model postulates that APP works as a receptor that mediates signals from membrane 
to nucleus in a process known as Regulated Intramembrane Proteolysis (RIP) (Brown, Ye 
et al. 2000). For example, the extracellular domain of APP has been shown to bind to Tag1 
in a ligand-receptor model and Tag1-APP binding can regulate neurogenesis. Enhanced 
neurogenesis of Tag1 deficient neuronal stem cells was reversed after expression of AICD. 
Instead, AICD with a mutation in the Fe65 binding site could not rescue the neurogenesis 
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defect, supporting a signaling role for the AICD-Fe65 complex (Ma, Futagawa et al. 2008). 
Similar fragments of APLP1 and APLP2 (named ALID1 and ALID2) can also potentially 
contribute to  gene expression regulation (Scheinfeld, Ghersi et al. 2002); however 
evidence for their role in neurogenesis and signaling function is lacking, and, as discussed 
above, we could not  show a direct signaling role of the AICD (Hebert, Serneels et al. 
2006).  
 
1.4 Temporally and tissue specific regulated expression of APP family 
proteins 
 
One of the determinants of the function of gene duplicates is the modification of their 
regulatory proximal elements which can lead to transcriptional divergence. In turn, 
transcriptional divergence is likely to result in diversification of the duplicates with refined 
functions instead of redundant functions. In particular, genetic differences in regulatory 
elements of genes that are expressed in the developing cortex have been proposed as a 
primary force influencing the emergence of mammalian brains (Johnson, Kawasawa et al. 
2009; Zhang, Landback et al. 2011). Members of the APP family proteins are characterized 
by a specific tissue expression during different developmental stages which is important to 
keep in mind when discussing physiological functions. 
The genomes of D.melanogaster and C. elegans each contain only one APP ―like‖ gene. 
APl-1 of C.elegans is expressed in neurons mainly and also in a few other cell-types 
(Hornsten, Lieberthal et al. 2007). Expression of APPL in D.melanogaster is restricted to 
the nervous system (Rosen, Martin-Morris et al. 1989). In mammals Aplp1 shows a neuron 
specific expression whereas App and Aplp2 are expressed by various cell types. Until 
recently, App was assumed to be expressed by all cell types in the brain (Lorent, 
Overbergh et al. 1995). However, using a specific antibody to stain App , Guo et al showed 
that App is expressed predominantly in neurons in the adult brain (Guo, Li et al. 2012). At 
the transcript level, a complementary pattern has emerged from in situ hybridization 
analysis of APP and Aplps transcripts during development of the cortex. Lopez-Sanchez et 
al have demonstrated that Aplp1 expression is restricted to the post-mitotic cortical plate 
during cortical development while Aplp2 transcripts show a specific distribution in the 
proliferating neurons in the ventricular and/subventricular zone. App finally appears both 
in the ventricular zone neurons as well as in  post-mitotic neurons of the cortical plate, thus 
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showing partial overlapping expression with both Aplp1 and Aplp2 (López-Sánchez, 
Müller et al. 2005). The same expression pattern is demonstrated in publicly available 
atlases of the developing cortex, including Genepaint and Eurexpress (Visel, Thaller et al. 
2004; Diez-Roux, Banfi et al. 2011). The region specific expression pattern of App, Aplp1 
and Aplp2 suggests functional specialization of each member during different stages of 
neuronal development. 
The genetic factors that contribute to the transcriptional divergence of APP duplicates are 
not well defined. However, analysis of the proximal element of APP and APP like proteins 
in different species reveal a CAGA box within the APP 5′-UTR which is not present in 
APP like proteins (Maloney, Ge et al. 2004). This CAGA box might regulate expression of 
APP in response to signaling pathways such as TGFβ (Maloney, Ge et al. 2004). More 
studies are needed to understand the contribution of the proximal element that control 
regulated expression of APP and APLPs.  
 
1.5 The interaction networks of APP, APLP1 and APLP2 show 
specificity 
 
Proteins are part of the dynamic networks of interactions that can show cell type and tissue 
specificity (Bossi and Lehner 2009). Evolutionary changes in specificity and strength of 
these interactions impact the function of the proteins and their networks (Robertson and 
Lovell 2009). Rewiring of the interaction network of paralogous protein is a clear sign for 
their functional refinement (Robertson and Lovell 2009). 
Several binding partners have been proposed for APP with various functional implications. 
(Reinhard, Hebert et al. 2005; Zheng and Koo 2011; Guo, Wang et al. 2012). In general, 
the interactors of APP can be divided into two groups: extracellular binders with a possible 
ligand mode of action and intracellular binders with a possible signaling mode of action. F-
spondin, Tag1, Reelin, Netrin, Lingo-1, Pancortins are among extra-cellular binders while 
Fe65, JIP, JNK, Mint1/X11, Dab1 are among intracellular binders of APP (Reinhard, 
Hebert et al. 2005; Zheng and Koo 2011; Rice, Townsend et al. 2012). If APP and APLPs 
share similar biological functions, then they are expected to be part of a similar protein 
network. However, a study by Bai et al challenges this idea by showing different networks 
of interaction for App and Aplps (Bai, Markham et al. 2008). Unexpectedly, a systematic 
comparison of in vivo brain interactome of App, Aplp1, and Aplp2 revealed different sets 
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of interactors for each paralogue. A significant proportion of identified App interactors 
were consistent with previously published data supporting the reliability of candidate 
interactors. Surprisingly, the combined analysis of interactors shows only one interactor in 
common; Ras GAP-activating like Protein 1 which binds to both Aplp1 and Aplp2 (Bai, 
Markham et al. 2008). In this study, ER chaperones populated the interaction network of 
App. Over-representation of ER chaperone in the App interaction network suggest 
sensitivity of App folding, the distinct interaction of Aplp2 with Rho family of GTPases 
such as RhoA and RAC1 can link APLP2 to G-protein signaling pathway (Bai, Markham 
et al. 2008). 
It is likely that the difference in the interaction networks of App and Aplps arises from 
different subcellular localization of each paralogue or from their differential expression 
pattern (Huminiecki and Wolfe 2004; Kaden, Voigt et al. 2009). Indeed, using fluorescent 
tagged version of APP and APLPs in HEK293 cells, Kaden et al showed that APLP1-YFP 
is primarily localized to the cell surface. Most of the APP-YFP was found in intracellular 
compartments such as the ER and endosomes and to a lesser extent in the Golgi apparatus. 
APLP2 was equally distributed at the cell surface and intracellular compartments showing 
partial overlapping localization with both APP and APLP2 (Kaden, Voigt et al. 2009). 
These findings suggest that in part specificity of interaction network of APP and its 
paralogues can be due to their differential subcellular localization. Regardless of the reason 
for different set of interactors, the specificity of interaction networks for APP duplicates 
can contribute to the separation of their role in different cellular contexts.   
  
1.6 Various roles of the APP members in the nervous system  
 
Loss of function studies is still the standard approach to deduce the physiological role of a 
gene. The APP family has been covered rather well in that regard with knock-outs (ko) in 
D. melanogaster, C. elegans and several combinations of gene ko in M. musculus.  The 
data are somewhat divergent, but overall they suggest strongly a role of the APP family in 
the central nervous system.   
1.6.1 The extracellular domain in development of C. elegans 
 
In C. elegans, the single gene encoding for members of the APP family, is called apl-1. 
The encoded protein is very similar to the mammalian counterpart  with  a large 
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extracellular and a short intracellular domain, while the Abeta sequence as such is lacking 
in APL-1 (Daigle and Li 1993). Loss of APL-1 leads to a molting defect resulting in 
developmental lethality (Hornsten, Lieberthal et al. 2007). In addition, the apl-1 null 
mutant worms are hypersensitive to the acetylcholinesterase inhibitor aldicarb supporting a 
role for APL-1 protein at synaptic junctions (Wiese, Antebi et al. 2010). Many reports 
stress the importance of the conserved intracellular domains of the APP family for its 
function, but, unexpectedly, the  conserved carboxyl terminus fragment of APL-1 is not 
involved in the  phenotype as demonstrated by rescuing the lethality of the apl-1 null 
mutant by c-terminus truncated version of APL-1 (Hornsten, Lieberthal et al. 2007). In 
contrast, the extracellular domain of APL-1 is sufficient to rescue both the lethality and 
hypersensitivity phenotypes. As this domain is soluble, these data suggest a receptor for 
APL-1 ectodomain, and indicate the importance of this domain in development (Hornsten, 
Lieberthal et al. 2007).  
1.6.2 D. melanogaster‟s APPL in axonal wiring and synaptic function 
 
Like C.elegans, D. melanogaster also carries one homologue of the APP gene, called Appl. 
Appl expression is first seen in developing neurons during axogenesis (Luo, Martin-Morris 
et al. 1990). Flies with an Appl null mutation are viable and fertile, but show subtle 
phenotypes. For instance at the  neuromuscular junction Appl null mutant flies  have a 
reduced number of neuromuscular buttons, whereas larvae over-expressing APPL show an 
increased number of buttons (Torroja, Packard et al. 1999). Interestingly, Torroja et al 
showed that APPL is transported to synaptic buttons and a highly conserved cytoplasmic 
YENPTY motif of APPL is required for promoting synapse formation (Torroja, Packard et 
al. 1999). This synaptogenic property might be mediated through interaction of Fasciclin II 
with APPL, while APPL is binding via its conserved cytoplasmic domain to APPBA1 at 
the synapse (Ashley, Packard et al. 2005).  APPL has also been implicated in regulation of 
neurite arborization (Leyssen, Ayaz et al. 2005). Leyssen et al (Leyssen, Ayaz et al. 2005) 
showed that both  APPL and its human homologue APP can promote post-developmental 
neurite arborization in D. melanogaster.  Similar to its synaptogenic role, APPL requires 
the conserved cytoplasmic YENPTY for its effects on neurite arborization, but this time the 
signal is transduced through the Abelson tyrosine kinase (Abl) pathway (Leyssen, Ayaz et 
al. 2005). These data suggest  a role for APP in the structural plasticity of neurons, whereas 
in pathological condition such as brain injury APPL might promote neurite arborization  
(Leyssen, Ayaz et al. 2005). Recently, it was shown that loss of APPL induced a 
developmental defect in the axonal outgrowth in mushroom bodies of D. melanogaster. 
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Heterozygosity for Abl kinase significantly enhanced the axonal phenotype of Appl mutant 
flies. Mechanistically, APPL turned out to interact with core components of the planar 
polarity pathway (PCP) mediating the WNT5a induced phosphorylation of Disheveled. 
Thus, it was suggested that modulation of PCP pathway by neuronal APPL might regulate 
developmental axonal wiring in mushroom bodies (Soldano, Okray et al. 2013). Overall, 
the loss of function experiments in flies and worms suggest that the ancestral App like gene 
has evolved to serve in the nervous system, in particular in synapse formation and function. 
While the Drosophila counterpart is really a nervous system protein, the situation in 
C.elegans is not completely clear. Absence of APL-1 results in  multiple  developmental 
defects for instance decreased body size, and egg-laying rate (Ewald, Raps et al. 2012). It is 
uncertain whether these phenotypes are the result of defects in the neuronal system or 
indicate that APL-1 also operates in other cells, and that its function is context-dependent.  
1.6.3 The APP family in M. musculus 
 
The situation in mammals is even more complex.  The different functions proposed for 
APP and its paralogues are not converging to a concrete model for APP family function. 
The single App KO mice are viable but show various subtle phenotypes such as 15-20% 
reduced body weight, disturbed forelimb strength and reduced locomotor activity (Zheng, 
Jiang et al. 1995). The interpretation that App ko mice show subtle phenotypes because of 
compensation by other APP members is not supported by expression studies of the other 
members of the APP family:  compensatory up-regulation of Aplp1 and Aplp2 transcripts 
were not observed in these mice (Zheng, Jiang et al. 1995).  
The alterations in muscular strength and decreased locomotor activity in the App null 
mutant mice might reflect the synaptic role of App in the central nervous system. 
Immunocytochemical analysis of App null mice revealed age-dependent increased glial 
fibrillary acidic protein (Gfap) immunoreactivity indicating gliosis and reduced staining for 
synaptic marker markers such as synaptophysin, synapsin and MAP-2 (Dawson, Seabrook 
et al. 1999). In addition, the mice showed impaired LTP recording which was highly 
correlated with gliosis (Dawson, Seabrook et al. 1999). Consistent with a defect in LTP, 
App null mutants mice spend more time finding the hidden platform in the Morris water 
maze test (Dawson, Seabrook et al. 1999) further suggesting a role for App in spatial 
learning. The defect in LTP was associated with attenuation of GABA-mediated inhibitory 
post-synaptic currents (Seabrook, Smith et al. 1999). Increased expression of calcium 
channel, Cav1.2, was suggested as potential mechanism regulating GABAergic synaptic 
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activity in inhibitory neurons (Yang, Wang et al. 2009). Further experiments will clarify 
the role of APP in synaptic plasticity of excitatory vs. inhibitory neurons.  
Mixed results were obtained on the role of App in the formation of dendritic spines 
(Bittner, Fuhrmann et al. 2009; Lee, Moussa et al. 2010; Jung and Herms 2012). Bittner et 
al (Bittner, Fuhrmann et al. 2009) used in vivo two photon imaging to show that γ-secretase 
inhibition reduced spine density in an App dependent manner. In their study layer III and 
Layer V cortical neurons of App ko mice showed a two fold increase in the number of 
dendritic spines (Bittner, Fuhrmann et al. 2009). In contrast, Lee et al  (Lee, Moussa et al. 
2010) used primary rat hippocampal neurons to show that down-regulation of App 
decreases the number of spines, whereas over-expression of App has the opposite effect. 
App needs both its extracellular and intracellular domains to mediate these effects. Golgi 
staining of spines of CA1 pyramidal neurons and layer II/III cortical neurons revealed a 
significant decrease in density and length of spines in App null mutants, confirming the 
role of APP in spine formation in vivo (Lee, Moussa et al. 2010). More recently, Tyan et al 
(Tyan, Shih et al. 2012) reported decreased spine density in primary neuronal culture of 
App null mutant mice confirming further the role of App in promoting spine formation. 
The discrepancy may arise from different methodology used to image the spines (Golgi 
staining vs. in vivo two photon imaging) or analyzing different types of neurons, i.e. deep 
layer vs. upper layer pyramidal neurons of cortex or CA1 neurons of hippocampus. One 
can speculate that the effect of APP is cell type specific and age dependent, which remains 
intellectually an unsatisfying explanation, as it brings little insight into the real function of 
App.  It is interesting however that the role of App in the regulation of neurite formation is 
reminiscent of the role of D. melanogaster APPL in regulation of arborization of neurites. 
Clearly, there would be some conservation of this role in evolution (Leyssen, Ayaz et al. 
2005; Soldano, Okray et al. 2013).  
It is noteworthy that the some of the phenotypes reported for App single ko mice are not 
observed in single Aplp1 and Aplp2 ko mice. Although both Aplp1 and Aplp2 single ko 
mice are much less extensively analyzed than the App knock-out, their  phenotypes do not 
overlap (Heber, Herms et al. 2000). Aplp1 ko mice appear normal both in forelimb strength 
and in reduced locomotor activity (Heber, Herms et al. 2000). Similar analysis of dendritic 
spines of Aplp2 null mutant neurons did not reveal alterations of spines in those mice 
(Midthune, Tyan et al. 2012). A very different example of non-conserved function is the 
feroxidase activity in App which is mediated by the  REXXE motif in the extracellular 
domain of App and is not found in Aplp1 and Aplp2 (Duce, Tsatsanis et al. 2010). Thus, 
although further work is needed, the different phenotypes of the single ko mice support the 
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idea that App is specialized in its functions at the synaptic junction, which are likely not 
fully compensated by Aplp1 and Aplp2. Lack of overt phenotypes in Aplp1 and Aplp2 
single KO mice does not exclude phenotypes that have escaped scrutiny at this moment.  
Combinations of the genetic deletions of App/Aplps have been generated (Heber, Herms et 
al. 2000; Guo, Wang et al. 2012). Expression of Aplp2 alone is sufficient for survival of the 
mice meaning that double deletion of App and Aplp1 is viable. However, in the absence of 
Aplp2, mice can survive only if they express both App and Aplp1. The viability of Aplp2 
single ko might indicate that App and Aplp1 can work together to compensate for a 
function that is dominated by Aplp2. At first glance, compensation by App/Aplp1 together 
for Aplp2 deficiency is a possibility, however, no compensatory up-regulation of App or 
Aplp1 was detected after deletion of Aplp2 (Heber, Herms et al. 2000; Aydin, Filippov et 
al. 2011). Alternatively, it is equally possible that APP family independent mechanisms are 
compensating for the lack of Aplp2. Indeed, combination of Aplp1 ko with App or Aplp2 
leads to different outcomes which is survival or lethality showing specificity in function of 
App and Aplp2 (Heber, Herms et al. 2000).   
Several studies support a role for App at the neuromuscular junction. A phenotype emerges 
only when App deletion is analyzed in an Aplp2 ko background (App/Aplp2 dko). These 
mice show reduced vesicle density in presynaptic active zone, excessive nerve terminal 
sprouting and aberrant apposition of presynaptic and postsynaptic markers indicating a key 
role for proper formation of synaptic structures at the neuromuscular junction (Wang, Yang 
et al. 2005; Yang, Gong et al. 2005). Interestingly, proper development of the 
neuromuscular junction requires App and Aplp2 in the presynaptic motor neurons and the 
post-synaptic muscles suggesting a transynaptic homophilic or heterophilic interaction 
between App and Aplp2 (Wang, Wang et al. 2009). In contrast to the prominent role for 
soluble App in C.elegans, expression of soluble App β (sAppβ) in the App/Aplp2 dko mice 
(App/Aplp2 sAppβki/ki) did not rescue the lethality or neuromuscular defects of App/Aplp2 
dko mice (Li, Wang et al. 2010). Strikingly, expression of soluble App α (sAppα) rescued 
the lethality of the App/Aplp2 dko mice (App/Aplp2 sAppαki/ki) (Weyer, Klevanski et al. 
2011) indicating that a few amino acid between α and β cleavage are instrumental in the 
biological function of sApp. However, App/Aplp2 sAppαki/ki showed a widened end plate, 
impaired neuromuscular transmitter release, and structural abnormalities at the 
neuromuscular synapses correlating with decreased grip strength. In the central nervous 
system, the mice showed impaired LTP accompanied with impaired spatial memory 
(Weyer, Klevanski et al. 2011). Thus, sAppα was not able to rescue several neurological 
27 
 
phenotypes, implying that full length APP is needed. Interestingly, App/Aplp2 sAppαki/ki 
mice did not have any spine or morphological defects in cortical or hippocampal neurons.  
It is very likely that the developmental function of App at the neuromuscular junction is 
mediated through its highly conserved YENPTY motif in its carboxyl terminus domain 
since expression of App with a single Tyr(682) to Gly (682), Y682G, mutation in an Aplp2 
null background, leads to the lethality and neuromuscular defects similar to App/Aplp2 dko 
mice (Barbagallo, Wang et al. 2011). This conserved Tyr (682) residue is both a docking 
site for several cytoplasmic partners and regulates processing of App. For example, a 
significant 15 fold increase in sApp-α together with a 3.5 fold decrease in sApp-β was 
detected in brain tissue from App
Y682G/Y682G
 mice, highlighting the importance of this 
residue in regulating App processing (Barbagallo, Weldon et al. 2010). NGF-TrkA 
signaling was proposed as the pathway responsible for regulating the phosphorylation of 
Tyr(682) of App. Tyrosine phosphorylation of APP was induced after NGF treatment of 
primary hippocampal neurons. The tyrosine kinase activity of TrkA receptor may mediate 
the NGF induced tyrosine phosphorylation of App (Matrone, Barbagallo et al. 2011). 
Further, it was shown that Y682G mutant neurons are insensitive to trophic activity of 
NGF, suggesting that phosphorylation of Tyr(682) can work down-stream of NGF-TrkA 
signaling to mediate the trophic effect of NGF. A nearby conserved phosphorylated 
Thr(668), part of pSer/Thr-Pro motif, is a docking site for Pin1 and this interaction can 
down regulate production of Aβ peptide from APP (Balastik, Lim et al. 2007). Pin1 is a 
unique peptidyl–prolyl cis/trans isomerase that can catalyse cis/trans isomerization of 
pSer/Thr-Pro motifs (Lu 2004). Binding of Pin1 to the pThr 668-Pro motif in c-terminus of 
App was shown to accelerate its isomerization leading to conformational changes in the c-
terminus of App (Pastorino, Ikin et al. 2004). In contrast to the instrumental role of 
Tyr(682) for survival of the mice during development, mutation in Thr(668) of App 
(T668A), in an Aplp2 null background, does not cause lethality or neuromuscular defects 
(Barbagallo, Wang et al. 2011) highlighting further the importance of tyrosine 
phosphorylation of APP during development.  
The fact that several loss of function App phenotypes emerge in an Aplp2 null background 
is evidence for genetic interaction but does not directly address the question whether there 
is really functional redundancy between these different paralogues. Further thorough 
analyses of the single mutant mice should be more informative to identify pathways in 
which the specific effects of Aplps become apparent. Indeed the question remains whether 
double mutants generate more severe phenotypes either because of complete loss of a 
redundant function or because of disruption of multiple independent pathways. 
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Transcriptional profiling of the different single mutant mice supports the second 
possibility. The transcriptomes of App and Aplp2 single ko mice reveal different sets of 
genes  (Aydin, Filippov et al. 2011). From the 1061 genes that are up or down regulated 
after deletion of Aplp2, only 181 are also found altered in App mutant mice (Yang, Turner 
et al. 1998; Aydin, Filippov et al. 2011). For instance, signalling molecules that regulate 
early response to synaptic activity such as KCNH6 (Erg2), Fos and Arc are significantly 
down-regulated in App mutant mice, but not in Aplp2 mutant mice, strengthening the 
evidence for APP function in synaptic plasticity. p21 is such an example that is down 
regulated in both APP and APLP2 ko mice cortices. p21 is a cyclin-dependent kinase 
inhibitor that regulate cell-cycle progression during G1 phase of cell cycle. Deficiency of 
p21 decrease cell cycle exit and enhances proliferation of neural stem cells by regulating 
the expression of pluripotency factor Sox2 (Kippin, Martens et al. 2005; Marqués-
Torrejón, Porlan et al. 2013). Thus, down-regulation of p21 in both App and Aplp2 null 
mutants may enhance the proliferation of neural stem cells. This is consistent with data 
from Lopez-Sanchez et al (López-Sánchez, Müller et al. 2005) that demonstrate  Aplp2 
transcripts is predominantly enriched in the proliferative zone of the developing cortex 
while App show a partial overlapping expression with Aplp2 in this area. Soluble fragment 
of APP and Aplp2 can promote proliferation of EGF expressing progenitors of 
subventricular zone (Caillé, Allinquant et al. 2004). Thus, overall it appears that App and 
Aplp2 indeed are partially redundant in neurogenic niches. Nevertheless, it should be noted 
that next to shared pathways between APP and APLP2, significant differences in the 
transcriptional response of App or Aplp2 deletion suggest that there are distinct pathways 
that are regulated by either App or Aplp2. It also of note that it is not yet clear whether 
expression changes in App and Aplp2 ko mice is due to direct transcriptional activity of 
intracellular domain of this protein or an indirect effect of loss of those proteins (Cao and 
Südhof 2001; Hebert, Serneels et al. 2006; Aydin, Filippov et al. 2011).  
1.7 A role of APP and APLPs in cortical development?  
 
The mammalian cortex has expanded rapidly across different species and this is associated 
with the evolution of neocortical related behaviour such as perception and cognition 
(Kriegstein, Noctor et al. 2006). The expansion of cortical surface is believed to underlie 
the transition from a smooth cortex (lissencephaly) to a highly folded cortex 
(gyrencephalic). Indeed, changes in the proliferative pattern of ventricular zone resident 
neural stem cells have been titled as ― a giant leap for mankind ― referring to the expanded 
surface of the human cortex due to more proliferative radial units (Rakic 1995). However, 
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neural progenitors outside the ventricular zone, for example the intermediate progenitors in 
subventricular zone, might be as well important players in the evolutionary expansion of 
the cortex (Kriegstein, Noctor et al. 2006; Fietz and Huttner 2011). In mice, APP and 
APLP2 are expressed in both ventricular and subventricular neurogenic niches of the 
developing cortex, and the question whether they play there a role in the development and 
evolution of the cortex is attractive (Lorent, Overbergh et al. 1995; López-Sánchez, Müller 
et al. 2005). Recently, several studies support such a role of the APP protein family in both 
migration and differentiation of neuronal precursor and progenitors during cortical 
development.  
 
 
Figure 4. Cell cycle network and schematic representation of the developing cortex. 
A) Part of the network that regulates the proliferation/differentiation balance of neural stem cells. 
Proteins that promote proliferation are depicted in green and differentiation promoting factors in 
red. B) The cells that compose the cortex are generated outside the cortex and reach their final 
destination by migration. For example, excitatory neurons are born in the proliferative regions of 
the developing cortex and reside in the cortical plate. The activity of neural stem cells is tightly 
regulated to ensure the balanced production of different neuronal subtypes. The two principle 
classes of neuronal progenitors are radial glia cells and intermediate progenitors which reside in 
VZ and SVZ respectively. The mitotic activity is induced when the radial glia cells approach and 
contact the ventricular lumen. This division can lead to generation of neurons which use the 
scaffold of radial glia cells to migrate and position in the cortical plate.  
 
1.7.1 Cell cycle of neural stem cells 
 
Two major neurogenic niches exist during cortical development; the ventricular zone (VZ) 
largely populated by the radial glia cells, and the subventricular zone (SVZ), populated by 
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the intermediate progenitors (Fig. 4B). More recently an additional class of progenitors is 
described in the outer subventricular zone OSVZ (OSVZ) of human, as well as of ferret 
and mouse (Fietz, Kelava et al. 2010; Hansen, Lui et al. 2010; Fietz and Huttner 2011). 
Initially neural stem cells mainly divide symmetrically to expand the pool of neural stem 
cells (E9.5-E11.5). This phase is followed by gradual increase of neurogenic divisions 
(E11.5-E17.5) (Dehay and Kennedy 2007; Farkas and Huttner 2008). Neurons can arise 
directly from radial glial cells or indirectly through intermediate progenitors which 
undergo symmetric final mitosis to produce two neurons (Dehay and Kennedy 2007; 
Farkas and Huttner 2008) (Fig. 4B). Before migration starts, the neuronal precursors need 
to exit the cell cycle. It is noteworthy that progression through the cell cycle and fate 
specification is highly coordinated (Dehay and Kennedy 2007; Farkas and Huttner 2008). 
Entry and exit from the cell cycle is regulated during the G1 phase of the cell cycle. 
Progression through the G1 is tightly regulated by Cyclin Dependent Kinases (CDK2/4/6) 
whose activity depends on their interaction with their activating cyclins subunits (E/D). 
When the activity of the G1 CDK-Cyclin is low, retinoblastoma tumour suppressor protein 
(RB) binds to E2F transcription factors suppressing the transcription of the genes required 
for cell cycle entry (Fig 4A). In response to mitogen in early G1, CDK4/6-CyclinD 
Phosphorylates RB resulting in its hyperphosphorylation. Hyperphosphorylated RB is 
inactive and dissociates from E2F transcription factors leading to the transcription of the 
genes necessary for transition to S phase of the cell cycle (Figure 4A). Consistent with an 
anti-proliferative role for RB, telencephalon specific deletion of RB enhances the 
proliferation of the neural progenitors and an increase in the size of the telencephalon 
(Ferguson, Vanderluit et al. 2002). Active E2F1 promotes the expression of CDK2/CylinE 
which triggers the G1-S transition in late stages of the G1. The activity of the CDKs is 
negatively regulated by CDK inhibitors (CDKIs). There are two classes of the CDKIs: the 
INK4 family (p15, p16,p18 and p19) and the CIP/KIP (p21, p27, p57). In neural stem cells 
of the adult brain loss of p21 results in increased proliferation of stem cells followed by 
their exhaustion. These data show that the cell cycle inhibitor p21 is necessary to maintain 
the pool of neual stem cells in the adult brain by regulating their quiescence (Kippin, 
Martens et al. 2005). More recently, it was shown that P21 regulate the pool of neural stem 
cells by suppressing the expression of Sox2 which is necessary transcription factor for 
selfrenewal of neural stem cells (Marqués-Torrejón, Porlan et al. 2013).  It is interesting 
that p21 not only regulate the activity of the G1 CDK but also link the cell cycle 
progression to cell fate decisions mechanisms. p27 is another CDKI which control activity 
of the CDK2/Cyclin E during G1-S transition. Interestingly, p27 deficiency promotes 
neuronal differentiation by stabilizing Neurogenin2 (Ngn2) in a cell cycle independent 
manner (Nguyen, Besson et al. 2006). Together, these findings suggest that cell cycle and 
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cell fate mechanism are interconnected with some proteins regulating both proliferation 
and differentiation (Fig 4A).  
Early studies of cortical neurogenesis proposed a model in which the length of the cell 
cycle determines the output of the division. Takahashi et al used S-Phase labelling of 
dividing neural stem cell to show that the length of the cell cycle increases during cortical 
development. This increase in the cell cycle length is accompanied by increased rate of 
neurogenesis meaning that early short cycles expand the pool of neural stem cell, whereas 
longer cycles in later stages of cortical development produce more neurons (Takahashi, 
Nowakowski et al. 1995; Takahashi, Nowakowski et al. 1996). Currently, converging 
evidence suggest that the progressive increase in neurogenesis is mainly due to the 
lengthening of the G1 phase of the cell cycle. Based on this model, differentiative divisions 
have longer G1, and the reverse is true for proliferative divisions (Calegari and Huttner 
2003; Dehay and Kennedy 2007). Calegari and Huttner used specific inhibitor of CDK2 
(Olomoucine) to show that lengthening of G1 progression increases the number of neuron 
generating divisions (Calegari and Huttner 2003). On the contrary over-expression of 
CDK4/Cyclin D1 shortens the G1 leading to increased number of proliferative divisions 
(Lange, Huttner et al. 2009; Pilaz, Patti et al. 2009). Over-expression of cdk4/cyclin D1 did 
not affect cell size or the cleavage angle of the division, but increased the number of 
divisions that produce basal progenitors confirming the idea that G1 cdk activity is a major 
determinant of the differentaitive vs. proliferative division (Lange, Huttner et al. 2009). 
Similar to developmental neurogenesis, over-expression of cdk4/cyclin D1 in the adult 
hippocampus expand the pool of adult neural stem cells suggesting conservation of this 
developmental pathway in adult neurogenesis (Artegiani, Lindemann et al. 2011). Based on 
these finding, the "cell cycle length" model proposes that the speed of G1 determines the 
fate of the daughter cells, perhaps by regulating their exposure to extrinsic differentiation 
factors (Calegari and Huttner 2003; Caviness, Nowakowski et al. 2009).  
1.7.2 Radial migration and the role of APP proteins  
 
Post-mitotic neurons born in neurogenic niches migrate towards the cortical plate using the 
fibers provided by the radial glia cells (Fig. 4B). This mode of migration is called glia 
guided migration. The glia guided migration stops at a cellular layer populated by Cajal-
Retzius (CR) cells. CR cells produce Reelin which binds to ApoER2 and Vldlr receptor to 
signal via Dab1 to control the end stage of neuronal migration by promoting glia 
independent somal translocation (Franco, Martinez-Garay et al. 2011). Triple deletion of 
App, Aplp1 and Aplp2 result in reduced number of CR cells and accumulation of neurons 
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that over-migrate to the marginal zones of the developing cortex (Herms, Anliker et al. 
2004). Likewise, deficiency of presenilin-1 decreases the number of CR cells and cause an 
ectopic accumulation of neurons in the marginal zones of the developing cortex (Hartmann, 
Strooper et al. 1999), suggesting the importance of  APP processing in CR cell function. In 
contrast to the over-migration phenotype, Young-Pearse et al (Young-Pearse, Bai et al. 
2007) showed that single knock-down of APP in wt brain inhibits migration of cortical 
neurons and APP over-expression promoted the migration of neurons which again depends 
on the conserved YENPTY in the carboxyl terminus. It is noteworthy that endogenous 
expression of Aplp1 and Aplp2 could not rescue the effect of shRNA, but their over-
expression rescued the migration phenotypes, indicating that regulated expression of App 
and Aplps is critical for their function (Young-Pearse, Bai et al. 2007). Down-stream, 
DISC1 is another interactor of APP with key roles during progenitor proliferation and 
neuronal migration (Bradshaw and Porteous 2012). Over-expression of DISC1 can 
significantly rescue the migration effect observed after Dab1 and APP down-regulation 
(Young-Pearse, Suth et al. 2010). Upstream, binding of different isoforms of Pancortins 
mediate different effects on processing of APP. Using an unbiased assay for identification 
of ectodomain binders of APP, Rice et al showed that pancortins can bind to APP and 
binding of Pancortin 1 and 2 (B-domain containing pancortins) can significantly decrease 
Abeta processing of APP (Rice, Townsend et al. 2012).  Down-regulation of Pancortin 1 or 
over-expression of Pancortin 4 resulted in similar migration defects observed after down-
regulation of APP in developing cortex suggesting opposite roles for different isoforms of 
the Pancortins (Rice, Townsend et al. 2012). Expression of Pancortin 1 or APP could 
rescue the delayed migration of pancortin 4 over-expressing migratory neurons (Rice, 
Townsend et al. 2012). Similar to Pancortins, Reelin interacts with the extracellular domain 
of APP in primary hippocampal neurons (Hoe, Lee et al. 2009) and Dab1 interacts with the 
highly conserved YENPTY motif in the carboxyterminus of APP. This interaction most 
likely depends on the phosphorylation of tyrosine highlighting further the importance of 
this residue for developmental functions of APP proteins (Howell, Lanier et al. 1999). 
Extracellular interaction of APP with Reelin and intracellular binding to Dab1 shows that 
APP might work together with ApoER2/Vldlr as (co)receptor to mediate the Reelin effect 
during migration of neurons. Indeed, Dab1 over-expression could rescue the blocked 
migration induced by APP shRNA in the developing cortex, further suggesting that Dab1 
might act down-stream of APP and Reelin complex (Young-Pearse, Bai et al. 2007). From 
these findings, a model emerges in which the ectodomain of APP binds to Reelin and 
Pancortins at the cell surface which leads to signal transduction through down-stream 
effectors such as Disc1 and Dab1 to regulate neuronal migration. It is very likely that 
phosphorylation of YENPTY motif at the C-terminus plays a central role in the regulation 
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of cortical migration. However, this model does not explain the reduction of CR cell in 
triple ko mice (Herms, Anliker et al. 2004), unless Reelin affects the survival of CR cells in 
a cell-autonomous way. It is likely that early neurogenesis is affected by APP proteins 
because CR cells are among the first neurons that are born during development.   
It might be that Reelin has a dual site of action in the developing cortex. Similar to post-
mitotic migratory neurons, Reelin-Dab1 can directly signal to radial glial cells regulating 
their morphology and rate of neurogenesis (Hartfuss, Förster et al. 2003; Lakomá, Garcia-
Alonso et al. 2011; Pérez-Martínez, Luque-Río et al. 2012). Regarding the dual site of 
action of Reelin, it is likely that during cortical development App and Aplp2 can regulate 
Reelin signalling both in migrating neuron and proliferating neural stem cells. Moreover, 
the YENPTY motif is also present in App like proteins raising the possibility that Reelin 
can also signals through Aplps to control migration and differentiation of cortical 
precursors and progenitors.  
Altogether, the current findings do not converge to a concrete model for APP protein 
family function during cortical development. Moreover, it is not clear to what extent App 
and Aplps have specialized function in different neuronal events such as migration and 
differentiation.  
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Chapter II: Rationale, Aims and Approach 
Expression of amyloid precursor protein (APP) and its two paralogues, APLP1 and APLP2 
during brain development coincides with key cellular events such as neuronal 
differentiation and migration. However, the neurodevelopmental roles of APP and APLPs 
remain controversial. When analyzing the function of APP and APLPs, a primary 
assumption made by many investigators is that the APP proteins are redundant. However, 
the early embryonic lethality of triple ko mice precludes the generation of sufficient 
number of mice for careful analysis of neurons (less than 6.25% theoretical chance of triple 
ko embryos from viable parents)(Bergmans, Shariati et al. 2010) . Previously, we 
approached these problems by generation of an embryonic stem cell line with triple 
deletion of App/Aplp1/Aplp2. The triple ko ES cells were differentiated to neurons in vitro 
and were analysed for different parameters such as migration and synaptic activity 
(Bergmans, Shariati et al. 2010). However, we did not find any obvious phenotype. This 
prompted us to further investigate the role of the APP gene family in vivo. We started by 
the generation of the chimeric mice with tKO neurons incorporated in a wt background 
brain using a morula aggregation technique. Using this technique, we showed that triple ko 
neurons can be generated in vivo and can migrate to the cortex (Bergmans, Shariati et al. 
2010). However, we could not generate sufficient numbers of mice for in depth analysis of 
neurons and neuronal precursors in vivo.  
The enrichment of Aplp2 expression in the proliferative zones of the developing cortex is 
compatible with a role of this protein in early proliferation and differentiation of neuronal 
precursors prior to migration. Moreover, among the different combinatorial genetic 
deletions of App/Aplps in mice, only App/Aplp1 double ko is a viable genotype, supporting 
a crucial and distinct developmental role for Aplp2 (Herms, Anliker et al. 2004). Therefore, 
we down-regulated Aplp2 by shRNA in wt mice as well as in App/Aplp1 dko mice. We 
avoided lethality by down-regulating Aplp2 only in a subpopulation of cells in the ventral 
telencephalon. This was done by in utero electroporation of shRNA against Aplp2. We 
investigated the effect of the loss of Aplp2 function in the proliferation and differentiation 
of progenitors, and migration and final positioning of cortical excitatory neurons using 
specific promotors to drive cell specific expression of the shRNA.  
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Chapter III: Methods and Materials 
The following chapters partly correspond to the following research article:  
S. Ali M. Shariati et al, APLP2 regulates neuronal stem cell differentiation during cortical 
development, Journal of Cell Science, 126, 2013.  
 
3.1 DNA constructs  
We used two different approaches to down-regulate expression of the APLP2. First, we 
have used a type III RNA polymerase promoter (U6) to express APLP2 shRNA. The 
hairpin itself is composed of the 29nt followed by 7nt loop structure and 29nt reverse 
complement sequence. Trancription of shRNA by U6 promoter produces shRNAs that are 
recognized by miRNA processing enzyme to generate targeting sequence (Rossi 2008). In 
the second approach, the shRNA is flanked by the genomic sequence of a naturally present 
miRNA, in this case Let7f2. The let7f2 based shRNA is expressed from an intron of the 
GFP allowing cell specific expression by using RNA polymerase II expression (Chang, 
Elledge et al. 2006).   
The APLP2 shRNA1 (GI562807) (sequence: 5‘-
CGATTACAATGAGGAGAATCCAACCGAAC-3‘), the APLP2 shRNA2 (GI562808) 
(Sequence 5‘-ATGAAGGCTCTGGAATGGCAGAACAAGAC-3‘) and control shRNA 
(scrambled sequence: 5‘-GCACTACCAGAGCT AACTCAGATAGTACT-3‘) driven by 
the U6 promoter were obtained from Origene (Rockville, USA). 
The pCAG-EGFPintron-let-7f based shRNA expression system was constructed as 
followed. The synthetic intron found in the psicheck2 plasmid (Promega, Leiden, The 
Netherlands) was PCR amplified using Promega IntronF (5‘-
CGAAGGTAAGTATCAAGGTTACAAGACAG-3‘) and R (5‘-
GACGTAGCCTGTGGAGAGAAAGGCAAAGTG-3‘) primers. The intron was then 
inserted into EGFP by overlap-PCR using two inner primers for 5‘ (5‘-
TGATACTTACCTTCG GGCATGGCGGACTTGAAG-3‘) and 3‘arms (5‘-
TCTCTCCACAGGCTACGTCCAGG AGCGCACCATCTTCTTC-3‘) of EGFP and two 
outer primers for 5‘ (5‘-GCCACCGGTCGATCCACGCCACCATGGTGAGCAAGGGCG 
AGGAG-3‘) and 3‘ (5‘-GATTGTCGACTTACTTGTACAGCTCGTCCATGCCG-3‘) 
arms. Next, XhoI and EcoRI restriction sites were added to the intron by PCR using Intron 
XhoI-EcoRI-F (5‘-
GAATTCCAATCTCGAGCTATTGGTCTTACTGACATCCACTTTGC-3‘) and Intron 
XhoI-EcoRI-R (5‘-CTCGAGATTGGAATTCAGCCTATCAGAAACGCAAGAG 
TCTTCTCTG-3‘) primers (pCAG-EGFP intron). The let-7f2 genomic sequence was 
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amplified from human genomic DNA using LET-7Fhu-MfeI (5‘-
TCATCAATTGTAACTCTCCTTCCCTTTCTCCCTTCTTAC-3‘) and LET-7Fhu-SalI 
(5‘-TCATGTCGACCATCAAAGGACCAGCCACTT-3‘) primers and cloned into the 
pCAG-EGFP intron vector digested by XhoI and EcoRI. This intermediate construct 
contains the genomic sequence of human let-7f2 precursor including the mature let-7f 
sequence. In order to remove this mature sequence and facilitate cloning of shRNAs, the 5‘ 
and 3‘ arms of the let-7f scaffold were amplified using two inner primers: 5‘arm (5‘-
GGCGCGCCCTCGAGCCATCTTCAGCCTATGTGGG-3‘) and 3‘arm (5‘-
GGCGCGCCG AATTCTCTTCTCCGACTGGCTCTGTTC-3‘) scaffold and two outer 
primers: Let7F-XhoI (5‘-CAATCTCGAGGTGCTCTGTGGGAT-3‘) and Let7F-EcoRI 
(5‘-CAATGAATTCGT ACCACCGTGGGA-3‘). The PCR product was cloned into the 
intermediate construct resulting in the pCAG-EGFPintron-let-7f plasmid. For shRNA 
cloning, overlapping DNA oligonucleotides were designed to embed the shRNA into the 
let-7f scaffold sequence. The shRNAs for APLP2 and mCherry were obtained after 
annealing the following oligonucleotides: APLP2-let7-I (5‘-
CTCGAGGTGCTCTGTGGGATCGCTGCTGGGT 
TCGGTTGGATTTAGGGTCATACCCCATCTTG-3‘); APLP2-let7-II (5‘-
GAATTCGTAC 
CACCGTGGGACGCCACTGGGTTCGGTTGGATATCTCCAAGATGGGGTATGAC-
3‘); mCherry-let7-I (5‘-
CTCGAGGTGCTCTGTGGGATGATGTTGACGTTGTAGGCGCCTT 
AGGGTCATACCCCATCTTG-3‘); mCherry-Let7-II (5‘-GAATTCGTACCACCG 
TGGGAGATACTGACGTTGTAGGCGCCATCTCCAAGATGGGGTATGAC-3‘) and 
PCR amplified using pre-Let7F and pre-Let7R universal primers. The resulting shRNAs 
were digested and cloned into the pCAG-EGFPintron-let-7f plasmid using XhoI and EcoRI 
restriction sites. 
BLBP-shRNA mir: For cell-specific expression into radial glia cells, the BLBP promoter 
was amplified from mouse genomic DNA using BLBP-F (5‘-CAATGTCGACAG 
CACAGCAGAAAGGGAAAA-3‘) and BLBP-R (5‘-
GGTGGGCGCGCCAGGCAGGAACT GGAGGAACTC-3‘) primers and cloned into the 
pCAG-EGFPintron-let-7f digested by SalI and AscI, thus replacing the CAG promoter by 
the mouse BLBP promoter.  
T-shRNAmir: The tubulin alpha promoter was chosen to drive neuronal expression and 
amplified from mouse genomic DNA using T-F (5‘-ACCTACTAGTGTATTAGAA 
GGGATGGCTCA-3‘) and T-R (5‘-ACCTACCGGTGGTTGCTGCTTCGCGGCTGCC-
3‘) primers and cloned into the pCAG-EGFPintron-let-7f digested by SpeI and AscI. For in 
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utero electroporation, DNA preparations, included endotoxin removal treatment, were 
obtained using Qiagen EndoFree Plasmid Maxi Kit (Qiagen, Venlo, Nethelands), with final 
concentration between 2-3 µg/µl plasmid DNA.  
3.2 Western blot  
Total cell lysates of cortical neuron cultures or HEK293 were prepared in cell lysate buffer 
(1 % Triton-X100, with protease inhibitors in PBS). 20 µg of protein was separated on a 
NuPAGE 4 %-12 % (Invitrogen), transferred to nitrocellulose and membranes were 
incubated overnight at 4 °C with the following primary antibodies: APLP2 (CT12 a kind 
gift from Dr. Thinakaran), V5 antibody (1:10000-mouse, Invitrogen Gent, Belgium), APP 
antibody (B63-1:5000, custom made rabbit antibody), GAPDH (1:5000-mouse, HyTest), 
Actin (1:1000-mouse, Sigma-Aldrich, Diegem, Belgium) and detected with HRP 
conjugated secondary antibodies using a ECL chemiluminescence detection kit 
(PerkinElmer Life Sciences, Zaventem, Belgium). The density of bands was quantified by 
densitometry using Aida Image Analyser 4.27 (Raytest, Straubenhardt, Germany) and 
linearity of the signal was tested using different dilution of total cell lysate. 
3.3 Cell cultures  
Mouse embryonic cortical neurons were prepared as described previously (Banker & 
Goslin, 1988) and plated at a density of 100000 cells per cm
2
 on poly-L-lysine (PLL) 
coated dishes. Neurons were transfected before plating using nucleofection (Amaxa, 
Cologne, Germany).  HEK293 cells over-expressing V5 tagged APLP2 were grown in 
DMEM/F12 with 10 % Fetal Calf serum (FCS) and were transfected with shRNA 
expressing construct using TransIT®-LT1 transfection reagent (Mirus, Madison, USA). 
  
3.4 Matrigel assay for migration 
E14 embryonic cortices were dissected and digested by papain for 20 min at 37 °C. After 
subsequent mechanical dissociation, cells were transfected by nucleofection (Amaxa) 
followed by overnight shaking (350rpm) at 37°C to form aggregates. The aggregates were 
embedded in Matrigel (BD Biosciences, Erembodegem, Belgium) on coverslips and fixed 
in 4 % paraformaldehyde (PFA) after 3 to 4 days. For live imaging from one day after 
plating onwards, coverslips were mounted in a closed metal chamber and images were 
acquired at 20 min intervals for up to 24 h using an inverted Olympus Cell
R
 microscope. 
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3.5 Knock-out mice  
APP/APLP1 double knock-out mice were described previously and generated by genomic 
deletion of the promoter and initiation codon of APP and APLP1 loci (Heber, Herms et al. 
2000; Herms, Anliker et al. 2004). Wt embryos were from C57/Bl6 background.  
 
3.6 In utero electroporation 
All animal experiments were approved by the Ethics Committee of the K.U.Leuven. 
Pregnant mice were anesthetized by intramuscular injections of 88 μg ketamine and 132 μg 
xylazine per gram of body weight. The uterine horns were exposed and the plasmids (1-
2 μg/μl) mixed with Fast Green (Sigma) were microinjected in the lateral ventricles of 
E14.5 mouse embryos. Five current pulses (50 ms pulse/ 950 ms interval) were delivered 
across the head of the embryos (36 V) targeting the dorsal-medial part of the cortex. After 
2-4 days, embryos were collected and perfused with PBS and 4 % PFA and the brains 
postfixed for 6-10 h in 4 % PFA at 4 C. 
3.7 Immunocytochemistry 
Coronal vibratome sections of the fixed embryonic brains were prepared with 100 μm 
thickness.  Subsequently,  the sections were permeabilized and blocked at RT for 1 h in 
PBS/ 0.3  % Triton-X100/ 3  % BSA/ 5  % goat or donkey normal serum, incubated with 
the primary antibody at 4 C overnight followed by the secondary Alexa conjugated 
antibodies for 2 h at room temperature (Invitrogen). For BrdU detection, slices were pre-
treated with 1M HCl (10 min 4 C) and 2 M HCl (10 min RT and 20 min 37 C) with 
subsequent washes in 0.1 M borate buffer.  
The following primary antibodies were used: chicken anti-EGFP (1:500; Aves labs, 
Oregon, USA), rabbit anti-Ki67 (1:300; Novacastra, Diegem, Belgium), rabbit anti-Tbr2 
(1:1000; Abcam, Cambridge, UK), rabbit anti-PH3 (1:300; Cell signalling, Leiden, The 
Netherlands), rabbit anti-III-tubulin (1:1000, Abcam), mouse anti-BrdU (1:200; Roche, 
Vilvoorde, Belgium), rabbit anti-Cux1 (1:500; Santa-Cruz, Heidelberg, Germany), goat 
anti-Sox2 (1:150; Santa-Cruz). Nuclei were visualized with DAPI. 
3.8 Cell cycle exit 
One day after in utero electroporation, pregnant mice were injected intraperitoneally with 
BrdU (75 mg/kg, Sigma-Aldrich). After another 24h the brains were collected, fixed and 
immuno-stained using anti-EGFP, anti-BrdU and anti-Ki67 antibodies. The cell cycle exit 
rate was calculated as the ratio of EGFP
+
/BrdU
+
/Ki67
-  
cells (cells which are not in the cell 
cycle) divided by the number of EGFP
+
/BrdU
+
 cells (total number of dividing and non-
dividing cells).  
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3.9 Confocal imaging and quantification 
Confocal images were captured on a Nikon microscope (Eclipse; Ti A1) using an Apo 10× 
A/1.40 N.A. objective lens.  The images were acquired by Nis-Element software and the 
imaging parameters were kept constant during imaging. Ten to fifteen consecutive Z-
sections were obtained per brain slice. All images were processed using the ImageJ 
software (NIH).  
For cortical positioning: The entire length of cortical walls was divided into ten equal bins 
and the frequency of cells per bin was calculated by counting the cell bodies of EGFP-
Positive cells in each bin, divided by the total number of EGFP positive cells. 
For cell cycle exit: All the images were thresholded and BrdU+/EGFP+ cells were detected 
by the AND function of Image Calculator (ImageJ software). Next, the same function was 
used to find BrdU/EGFP double positive cells that are positive or negative for Ki67. 
3.10 Statistics 
Corresponding bins were compared using Student‘s t-test. The population distribution of 
two groups of neurons was compared using a non-parametric Mann–Whitney U test (P< 
0.05 as significance level). All statistical analysis and graph preparation were done by 
using GraphPad Prism5.  
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Chapter IV: Results 
To study the role of Aplp2 in neuronal development, we tested the effect of Aplp2 down-
regulation on cortical position of neurons. To this end, we performed the following 
experiments:  
 Identification of functional and specific shRNAs 
 Down-regulation of Aplp2 in wt cortices using in utero electroporation 
 Down-regulation of Aplp2 in dko cortices using in utero electroporation   
 Morphological studies of neurons and neuronal precursors 
 Cell specific interference with Aplp2 functions 
 Analysis of cell cycle variables  
In these experiments, we electroporated Aplp2 shRNA at E14 and removed the brain at 
E18 for migration and morphological studies. The neurons born on E14 are expected to 
reside in the upper layers of the developing cortical plate 4 days after electroporation 
(E18.5) (Figure 5).  
To analyze the cell cycle, differentiation and mitosis, we collected samples at E16.5 when 
many electroporated cells are still residing in the VZ/SVZ (Figure 5). 
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Figure 5. The experimental approaches used to study different neuronal processes.  
The DNA constructs expressing Aplp2 shRNA were electroporated at E14.5 Two days after 
electroporation, most of the cells are still residing in the proliferative zones of the developing 
cortex. We chose E16.5 (when many of the electroporated cells are still in the proliferative 
zones) to test the cell cycle exit, mitotic index and differentiation of neuronal precursor. Four 
days after electroporation, most of the targeted cells end up in the upper layers of the developing 
cortex. We performed the migration, morphological studies and cortical positioning analysis at 
E18.5.  
 
4.1 Identification of functional and specific shRNAs targeting Aplp2 
 
To examine the role of Aplp2 in cortical development, we tested the effect of four U6 
driven shRNAs on the expression of endogenous Aplp2 in mouse embryonic fibroblasts. 
We selected two different U6 driven shRNAs constructs (shRNA1 and 2) targeting 
different regions of the coding sequence of the Aplp2 transcript. To control the effect, we 
used a scrambled control shRNA construct that does not align significantly with any 
published NCBI mouse transcript sequence. Western-blot analysis of Aplp2-V5 over-
expressing HEK293 cells which were transfected with one of those shRNA constructs 
confirmed the down-regulation of Aplp2 protein (APLP2 shRNA1 more than 95 % knock-
down and Aplp2 shRNA 2 more than 80 % knock-down: Fig. 6A). Since Aplp2 shRNA1 
was more efficient for the down-regulation of Aplp2 protein, we used in most of our 
analysis this shRNA construct (in the further text named Aplp2 shRNA) and utilized the 
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second construct in initial experiments in order to validate the phenotype and exclude the 
possibility of off-target effects. Also in cultures of cortical neurons from E14 mice (Fig. 
13D) endogenous Aplp2 expression was clearly down-regulated by Aplp2 shRNA1 three 
days after transfection. Next, we tested the selectivity of the Aplp2 shRNAs by assessing 
their effect on highly related Aplp1 transcripts. Western blot analysis showed that Aplp2 
shRNAs do not change significantly the level of Aplp1 supporting the specificity of 
selected shRNAs (Fig. 6B).   
 
Figure 6. Western blot analysis of Aplp2 shRNA effect  
A) The selected shRNA1 and shRNA2 significantly down-regulate expression of Aplp2 –V5 that 
is overexpressed in Hek293 cells. On the left, the expression of Aplp2-V5 was assessed using a 
mouse antibody against the V5 tag and on the right the quantification of the APLP2 band 
normalized to actin loading control (n=2) is shown  B) APLP2 shRNAs does not change 
significantly Aplp1 level. The expression of Aplp1-V5 was assessed using a mouse antibody 
against the V5 tag. 
 
4.2 Down-regulation of Aplp2 in wt cortices does not change cortical 
positioning 
 
To address Aplp2 function, we expressed the Aplp2 shRNA constructs in cortical 
progenitors of wt mice at E14.5 by using in utero electroporation. Aplp2 is highly 
expressed in the developing cortex at E14.5 (Lorent, Overbergh et al. 1995; López-
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Sánchez, Müller et al. 2005) when upper layer neurons are generated (Molyneaux, Arlotta 
et al. 2007). In order to visualize electroporated cells, EGFP was co-expressed. As control, 
we used a scrambled control shRNA that does not align significantly with any NCBI 
mouse transcript sequence. Four days after electroporation, the time point when transfected 
precursors are expected to have differentiated into neurons and are residing in the upper 
layers of the cortical plate (Fig. 7A), we fixed the brains and analysed the position of 
labelled cells in coronal sections. For this purpose we divided the cortex into 10 equal bins 
and counted the relative number of EGFP-positive cells in each bin (Fig. 7A/B, see 
Material and Methods). Moreover, we analysed the difference of the entire population 
distribution (Fig. 7B, inset). Both types of analysis did not reveal any difference in the 
behaviour of Aplp2 shRNA expressing cells in respect to control shRNA cells (Fig. 7A/B). 
In both cases, EGFP-positive cells were mostly positioned in the upper layers of the cortex, 
which is marked by Cux1 (Cut like homeobox 1 )antibody (Fig. 7B). 
 
 
Figure 7. APLP2 down-regulation in wt cortices does not change cortical positioning of 
neurons.  
A) Confocal images of coronal slices of wt brains electroporated with constructs expressing 
Aplp2 shRNA or Ctrl shRNA together with GFP, 4 days after electroporation (E14.5-E18.5). 
Aplp2 shRNA expression does not lead to developmental differences respect ctrl conditions. B) 
Quantification of GFP+ cells of A. Bar graphs represent frequency distribution of GFP positive 
cells in ten equally divided bins from ventricle (10) to the pial surface (1) of the cortical wall. 
Values represent the mean ± STDV (n = 5; t-test). The inset scatter plot compares the population 
distribution of GFP+ cells. (n=3, 300-400 cells only are shown for clarity of graph; Values 
represent the median ± interquartile Mann Whitney test). 
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4.3 Down-regulation of Aplp2 in App/Aplp1 dko cortices affects cortical 
positioning 
 
Next, we considered the possibility that the overlapping function of App, Aplp1 and Aplp2 
throughout development (Heber, Herms et al. 2000) could have led to a compensation for 
the loss of Aplp2 function. To test this, we expressed Aplp2 shRNA in cortical progenitors 
from App/Aplp1 dko mice. Aplp2 down-regulation in App/Aplp1 dko resulted in a large 
number of EGFP positive-cells (54 %) residing in the Cux1 negative region, i.e. 
predominantly in the VZ/SVZ of the developing cortex (Fig. 8A/B). Similar to wt mice, the 
majority of neurons electroporated with the control shRNA construct (App/Aplp1 dko) 
migrated to the upper layer of the cortical plate (Cux1-positive layer, Fig. 8A). This 
indicates that Aplp2 is an important component of the machinery responsible for proper 
neuronal progression towards the cortical plate. To guard against possible off-target of the 
Aplp2 shRNA construct, we used a second shRNA (i.e. shRNA2) to target Aplp2 in the 
developing cortex. Again, we find only a change in the cortical positioning of cells 
transfected with Aplp2 shRNA2 in App/Aplp1 dko mice (Fig. 9 A,B). Moreover, the 
inability of both Aplp2 shRNA constructs to induce any phenotype in wt cortices (Fig. 
7A,B and Fig. 9A,B) argues for the specificity of our approach. 
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Figure 8. APLP2 down-regulation in dko cortices change cortical positioning of neurons.  
A) Confocal images of coronal slices of dko brains electroporated with constructs expressing 
Aplp2 shRNA or Ctrl shRNA together with GFP, 4 days after electroporation (E14.5-E18.5). 
Aplp2 shRNA expression leads to developmental differences respect wt and ctrl conditions. B) 
Quantification of GFP+ cells of A. Bar graphs represent frequency distribution of GFP positive 
cells in ten equally divided bins from ventricle (10) to the pial surface (1) of the cortical wall. 
Values represent the mean ± STDV (n = 5; t-test). The inset scatter plot compares the population 
distribution of GFP+ cells. (n=3, 300-400 cells only are shown for clarity of graph; Values 
represent the median ± interquartile Mann Whitney test). 
 
 
Figure 9. Confocal images (left) and quantification (right) of the effect of a second Aplp2 
shRNA.  
See the text and legend of figure 7 and 8 for full description.  
  
49 
 
4.4 Morphology and migratory behaviour of “Triple knock-out” cells 
remain unchanged 
 
Next, we asked whether the morphology of neurons that are moving towards the cortical 
plate is different in dko vs. ―triple ko‖ neurons (―triple ko‖ refers to APP/APLP1dko cells 
expressing APLP2shRNA). Neurons born in the proliferative zones of the cortex acquire a 
multipolar morphology in the lower part of the intermediate zone. As they migrate towards 
cortical plate, the neurons change from multipolar to bipolar morphology with a thick 
leading process and a thin trailing process. The transition from multipolar to bipolar 
morphology is essential for proper positioning of the neurons in the cortical plate. A defect 
in acquiring the bipolar morphology could explain the observed changes in cortical 
positioning of the cells (Jossin and Cooper 2011). Careful microscopic analysis revealed 
that this is not the case: neurons in both groups displayed the typical bipolar morphology of 
migrating neurons with a thickened leading edge and a thinner trailing process (Fig. 10A), 
indicating that Aplp2 is not essential for the acquisition of the morphological polarization 
required for proper migration. To assess directly neuronal migration, we monitored the 
migration speed and distance of dko neurons either expressing the control shRNA or the 
Aplp2 shRNA through the use of an in vitro migration assay in Matrigel (Calderon de 
Anda, Gartner et al. 2008). We did not detect any differences in the distance that double or 
―triple ko neurons‖ migrate away from the explants (Fig. 2B). Moreover, live imaging of 
migrating neurons did not reveal differences in the speed of neuronal migration nor in the 
morphology nor in the behaviour of the migrating neurons (Fig. 10B). Thus, neither a 
morphological defect nor the migratory behaviour of neurons is the cause of altered cortical 
positioning. 
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Figure 10. Morphology and in vitro migration of migrating neurons are not altered 
A) Confocal images of 20-25 (0.8 µm) consecutive z-sections illustrating morphology of dko 
migrating neurons transfected with Aplp2 shRNA or control shRNA. Drawings on the right 
depict the morphology of two migrating neurons (blue) and one positioned in the CP. The 
morphology of neurons in both groups is comparable. Scale bars: 25 µm. B) Images of control 
shRNA or Aplp2 shRNA transfected neuronal explants embedded in Matrigel 3 days after 
plating. The first upper graph shows the mean distance of EGFP+ cells from the margin of 
explants which does not change in ―triple ko‖ neurons. Values represent the mean ± s.d. (n=3 
different experiments, Control: 161 cells from 16 explants; shRNA: 182 cells from 18 explants, 
Student‘s t-test). The second upper graph, on the right, shows the overall distribution of neurons 
in both groups in respect to the margins of the aggregates. The lower graph shows that the 
velocity of neuronal movement does not change with expression of Aplp2 shRNA (n=2 
independent experiments, 29 cells for Aplp2 shRNA and 26 cells for control shRNA). Scale 
bars: 50µm. 
To test whether the migration delay was due to a change in the morphological 
differentiation of radial glia cells, which provide the scaffold for radially migrating 
neurons, we analysed the morphology of EGFP-labelled radial glia cells in E16.5 dko 
slices of mice with down-regulated Aplp2 from E14.5. The morphology of radial glia was 
similar in Aplp2 shRNA and control plasmid electroporated dko cortices: they were 
radially oriented, well aligned and spanned the entire cortical wall with branched basal end 
feet and apical connections (Fig. 11) (Chanas-Sacre, Rogister et al. 2000).  
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Figure 11.The morphology of radial glia cells remains unchanged.  
Confocal projection images of 20-25 consecutive z-sections (0.8 µm) of radial glia cells 
illustrating their ascending fibers (left) and end feet (right) in App/Aplp1 double knock-out 
cortices transfected with Aplp2 shRNA or Control-shRNA. In both groups the fibers span the 
entire cortical wall with branched end feet that are attached to the pial surface. Scale bars: 50µm 
(left), 25µm (right). 
 
4.5 “Triple knock-out” cells remain in a proliferative progenitor state 
 
Apart from the defective cortical positioning of ―triple knock-out‖ neurons described 
above, we also detected retention of ―triple knock-out‖ cells in the VZ/SVZ (Fig. 8A,B). 
To determine whether the cells arrested in the VZ/SVZ are progenitors which remain 
longer in a proliferative state, or neurons which fail to migrate away from the proliferative 
zones, we labelled the brain slices with the basal progenitor marker Tbr2 (T box brain 
protein 2)  (Fig. 12A). In dko cortices electroporated with the control shRNA a small 
number of EGFP positive cells were located in the VZ/SVZ and only 7 % (± s.d. 2,4 %, 
n=3) were Tbr2 positive, demonstrating that four days after electroporation, most of the 
cells became post-mitotic and migrated to the cortical plate (Fig. 12A). In contrast, in dko 
cortices electroporated with the Aplp2 shRNA, a large number of cells remained in the 
VZ/SVZ of which 29 % (± s.d. 3.5 %, n=3) expressed Tbr2 suggesting that they failed to 
differentiate into post-mitotic neurons (Fig. 12A). In addition, a Tbr2 negative population 
in the ventricular zone, most likely radial glia progenitors (Fig. 19), was still present (Fig. 
12A,B) and some cells (Fig. 12B) were still expressing phosphor-histone 3 (PH3), a marker 
tightly associated to chromosome condensation during mitosis (Goto, Tomono et al. 1999), 
showing that they were undergoing mitosis. In contrast, in dko cortices electroporated with 
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the control shRNA, we very rarely found mitotic PH3/EGFP-positive cells and only 
observed a very small number of radial glia cell progenitors. 
Altogether, these data suggest that Aplp2 plays a role in the normal progression of the 
neuronal differentiation program from precursors to post-mitotic neurons. 
 
Figure 12. The arrested „‟triple ko‟‟ EGFP positive cells express progenitor and mitotic 
marker.  
A) Confocal images of coronal cortical sections labelled with Tbr2 antibody four days after 
electroporation show progenitors in the VZ/SVZ of Aplp2 shRNA treated cortices. Scale bars: 
100 µm. B) App/Aplp1 double knock-out cortices transfected with Aplp2 shRNA or control 
shRNA labelled with the mitotic PH3 marker show mitotic Aplp2 shRNA transfected cells (filled 
arrows). Scale bars: 50 µm. 
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4.6 Aplp2 has a progenitor specific function and is dispensable for radial 
migration  
 
To substantiate the above hypothesis, we designed a construct to achieve cell-specific 
expression of the Aplp2 shRNA, based on the use of a let-7 microRNA embedded shRNA 
that can be expressed from cell-type specific promoters (Chang, Elledge et al. 2006) (Fig. 
13A). In our hand, the let-7 microRNA based shRNA was more effective in down-
regulation of cherry fluorescent molecule compared to the commonly used miR-30 
microRNA system in Hek293 cells (Fig. 13B). Its functionality for Aplp2 down-regulation 
was shown by western blot analysis of HEK293 cells expressing a V5 tagged Aplp2 cDNA 
and transfected with a shRNAmir construct (Fig. 13C). Similar to the U6-Aplp2 shRNA 
constructs (Fig. 6A), the Aplp2 shRNAmir construct reduced Aplp2 protein expression by 
about 90 %. Moreover, E14 cortical cultures transfected with Aplp2 shRNAmir, showed 
comparable down-regulation of endogenous Aplp2 to the U6-driven-shRNA (Fig. 13D). In 
addition, in utero electroporation of Aplp2 shRNAmir using the ubiquitous CAG promoter 
recapitulated the phenotype (14A) that was obtained by the U6 driven Aplp2 down-
regulation in dko mice (Fig. 8 A,B). 
 
Figure 13. Cell specific construct for Aplp2 down-regulation  
A) Schematic comparison of U6-shRNA and microRNA-based shRNA. U6 is a type III RNA 
polymerase promoter that is expressed ubiquitously, whereas microRNA based shRNA can be 
expressed from cell specific type II RNA polymerase promoters B) Down-regulation of the 
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cherry fluorescent molecule using miR30 or Let7f2 based shRNA  GFP construct in Hek293 
cells. Let7f2 construct appeared more powerful in down-regulating Cherry when compared to 
miR30 system. C) Western blot showing protein levels of Aplp2-V5 and actin (loading control) 
of HEK cells expressing Aplp2-V5 transfected with Aplp2 shRNAmir or control shRNAmir. The 
down-regulation obtained by the microRNA construct was about 90 % and comparable to the 
efficiency of the U6 shRNA1 construct (see Fig. 6A) D) Aplp2 and GAPDH (loading control) 
western blot of cortical cells transfected by shRNAmir or U6 shRNA directed against Aplp2. 
Comparable down-regulation was obtained by both constructs.  
This system allowed us to investigate the result of a cell specific loss of Aplp2 function by 
driving the expression of Aplp2 shRNA in neural progenitors and post-mitotic neurons 
using the Brain lipid-binding protein (BLBP) and Tubulin-α promoters respectively 
(Feng, Hatten et al. 1994; Gloster, Wu et al. 1994; Coksaygan, Magnus et al. 2006; 
Hashimoto-Torii, Torii et al. 2008). Differential expression of Tand BLBP promoters 
was confirmed by co-electroporation of T-mCherry with BLBP-EGFP in utero (Fig. 
14B). 
 
 
Figure 14. Down-regulation of Aplp2 by shRNAmir change the cortical positioning  
A) Confocal images of coronal slices of dko brains electroporated with constructs expressing 
Aplp2 shRNAmir or Ctrl shRNA from Let7 construct, 4 days after electroporation (E14.5-
E18.5). Aplp2 shRNAmir expression lead to the similar developmental defect as U6 driven 
shRNA. B) Confocal images (projection of 10-15 consecutive z-sections) of dko cortical slices 
transfected with Aplp2 shRNAmir or control shRNAmir under the control of Tα promoter. 
Neuronal down-regulation of Aplp2 does not change cortical positioning. Scale bars: 100µm. 
Expression of Aplp2 shRNAmir under the control of neuronal Tα promoter in dko post-
mitotic cells did not result in any changes in the cortical positioning of EGFP-positive cells 
when compared with control shRNA (Fig. 15A,B).  
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Figure 15. Neuronal Aplp2 shRNAmir does not alter cortical positioning  
A) Confocal images (projection of 10-15 consecutive z-sections) of dko cortical slices 
transfected with Aplp2 shRNAmir or control shRNAmir under the control of Tα promoter. 
Neuronal down-regulation of Aplp2 does not change cortical positioning. Scale bars: 100µm. B) 
Quantification of EGFP+ cells of D. Bar graphs represent frequency distribution of EGFP 
positive cells in ten equally divided bins from ventricle (1) to the pial surface (10) of the cortical 
wall. Values represent the mean ± s.d. (n=3; Student‘s t-test). The inset scatter plot compares the 
population distribution of EGFP+ cells. (n=3, 300-400 cells for clarity of graph; Values represent 
the median ± interquartile range, Mann Whitney test). 
In contrast, progenitor specific expression of Aplp2 shRNAmir caused the accumulation of 
cells in the VZ/SVZ similar to the phenotype that we observed using the U6 promoter (Fig. 
16A,B compare to Fig. 8A/B). In order to visualize the progeny of cells electroporated with 
BLBP Aplp2 shRNAmir after the BLBP promoter is switched off in young neurons, we co-
electroporated a mCherry expressing construct with the ubiquitous CAG promoter. Four 
days after electroporation we detected BLBP-EGFP positive cells only in the Aplp2 
shRNAmir expressing cortices (Fig. 16A). This supports a progenitor specific function of 
Aplp2 and the delay in the exit from the progenitor stage, further highlighting the 
importance of Aplp2 in neural differentiation of cortical progenitors. 
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Figure 16. Progenitor specific expression of Aplp2 shRNA is sufficient to retain cells in the 
proliferative zone of the developing cortex.  
A) Confocal images (projection of 10-15 consecutive z-sections) of dko cortical slices 
transfected with Aplp2 shRNAmir or control shRNAmir under the control of BLBP promoter. 
Progenitor specific expression of shRNA leads to retention of cells in the VZ/SVZ. Scale bars: 
100 µm. B) Quantification of EGFP+ cells of F. Bar graphs represent the frequency distribution 
of EGFP positive cells in ten equally divided bins from ventricle (1) to the pial surface (10) of 
the cortical wall. Values represent the mean ± s.d. (n = 3; **p < 0.01; ***p < 0.001, Student‘s t-
test). The inset scatter plot compares the population distribution of EGFP+ cells. (n=3, 300-400 
cells; Values represent the median ± interquartile range, ***p < 0.001, Mann Whitney test). 
 
4.7 Cell cycle variables are regulated by Aplp2 
 
In order to understand the role of Aplp2 during precursor proliferation in more detail, we 
chose to analyse in utero electroporated brains two days after electroporation instead of 
four days. After two days, a substantial number of progenitors can still be found in the 
proliferative zone of the developing cortex even under control conditions (Tabata and 
Nakajima 2001; Tabata and Nakajima 2008), allowing us to compare the proliferative 
fraction of cells under different conditions, whilst after four days most of the progeny 
deriving from in utero electroporated progenitors has been differentiated into neurons (Fig. 
7A,B). 
Initially, we analysed the position of Aplp2 shRNAmir expressing cells and found a higher 
number of cells compared to control transfected cells many of which were located closer to 
the ventricle (Fig. 17A). This initial observation suggested that Aplp2 may be involved in 
the regulation of progenitor proliferation. Alternatively, the higher number of cells simply 
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might reflect differences in electroporation efficiencies. To distinguish between these 
possibilities, we analysed the fraction of EGFP positive cells which were still proliferating 
under control and ―triple ko‖ conditions. To determine which fraction of the progenitor 
pool remains in the proliferative state, we examined cell cycle exit rates of EGFP-positive 
cells after in utero electroporation of E14 cortices and BrdU pulse labelling of S-phase 
cells 24h before collecting the brains at E16.5. This was followed by Ki67 staining, which 
is expressed throughout the cell cycle and thus labels all proliferating cells (Chenn and 
Walsh 2002). Hence, the cells which integrate BrdU and express Ki67 after 24h correspond 
to the proliferative pool, while Ki67 negative but BrdU positive cells correspond to the 
pool of cells that have recently exited mitosis, and consequently are young neurons (Fig 
17B). The rate of cell cycle exit was calculated as the ratio between EGFP+/BrdU+/Ki67- 
cells and the total EGFP+/BrdU+ population. This ratio was significantly decreased from 
74 % in ctrl shRNAmir expressing cells to 45 % in APLP2 shRNAmir dko cells, 
demonstrating essential functions of Aplp2 in the regulation of neuronal differentiation 
(Fig. 17B). In light of these findings, the observed decrease in neuronal progression and 
resulting changes in cortical positioning of ―triple ko‖ cells likely results from delay in the 
cell cycle exit rate and a delayed entry into the neuronal differentiation program.  
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Figure 17. Decreased cell cycle exit rate after Aplp2 down-regulation  
A) Confocal images (projection of 10-15 consecutive z-sections) of E16 dko cortical slices co-
transfected with Aplp2 shRNAmir or control shRNAmir at E14. Two days after electroporation 
more cells are found close to the VZ of the developing cortex in Aplp2 shRNA expressing 
cortices. Scale bars: 50 µm. B) Confocal images of dko cortices transfected by Aplp2 or control 
shRNA at E14.5 followed by BrdU injection at E15.5 and then triple stained for EGFP, BrdU 
and Ki67 at E16.5 (see scheme of the cell cycle exit assay). The graph shows the decreased cycle 
exit of Aplp2 shRNA expressing progenitors that is calculated by the ratio of 
EGFP+/BrdU+/Ki67- cells (filled arrows) divided by the total EGFP+/BrdU+. Open arrows 
indicate the cells that did not leave the cell cycle. Values represent the mean ± s.d. (n=5; **p < 
0.01; Student‘s t-test). Scale bar: 100µm. 
We reasoned that a reduced cell cycle exit rate can result in more mitotic cells in ―triple 
ko‖ conditions. To test this hypothesis, we labelled specifically mitotic cells using an 
antibody against phosphorylated histone 3 (Ser10). Two days after electroporation a two-
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fold increase in the number of mitotic cells was observed in VZ/SVZ of dko cortices 
electroporated with Aplp2 shRNAmir when compared to control shRNAmir (Fig. 18). 
 
 
 
Figure 18. Aplp2 down-regulation increases mitotic index.  
Confocal images cells labelled with the mitotic PH3 marker. Two days after Aplp2 down-
regulation the number of mitotic cells increased (filled arrows). Graph: mitotic index is 
calculated by the ratio of PH3+ cells divided by the total number of EGFP+ cells (values 
represent the mean ± s.d. (n=3; **p < 0.01, Student‘s t-test). Scale bar: 25 µm. 
 
The observed changes in progenitor proliferation raised the question of whether this had 
resulted in a different distribution of the progenitor and neuronal pools. The balance 
between progenitors and post-mitotic neurons depends on the ratio of neurogenic vs. 
proliferative radial glia cell division. A proliferative division can be self-renewing or 
leading to the generation of a radial glia cell and intermediate progenitor cells. These two 
principle classes of progenitors can be distinguished by specific molecular markers: Sox2 
for radial glia and Tbr2 for intermediate progenitor cells. We therefore used double-
staining of Sox2 and Tbr2 to evaluate the balance between proliferative and neurogenic 
division of radial glia cells after Aplp2 down-regulation. Aplp2 down-regulation in dko 
cortices significantly increased both Sox2 and Tbr2 EGFP-positive cells with a 
corresponding relative paucity of post-mitotic neurons (Fig. 4D). This result shows that 
lack of Aplp2 shifts radial glia cells towards proliferative division, implying that Aplp2 is 
involved in neurogenic division. 
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Figure 19. Aplp2 down-regulation increases the proportion of two major classes of cortical 
progenitors.  
Confocal images of Sox2-Tbr2 double stained slices transfected with Aplp2 shRNA or control 
shRNA. EGFP/Sox2 double positive progenitors: filled arrows; EGFP/Tbr2 double positive 
progenitors: open arrows. The graph shows that both classes of progenitors are increased after 
Aplp2 down-regulation (values represent the mean ± s.d. (n=3; *p <0.05, **p < 0.01, Student‘s 
t-test). Scale bars: 20 µm. 
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Chapter V: General discussion and perspectives  
Our data are consistent with the view that Aplp2 plays a key role in the differentiation of a 
neuronal progenitor into a neuron. The control of this step is essential during cortical 
development since there is a close link between the timing of the cell cycle exit and the 
determination of the laminar fate of the generated neurons (McConnell and Kaznowski 
1991). Hence, prospective cortical architecture is already determined at early 
developmental stages. 
We could unravel this function of Aplp2 by combining in utero electroporation with cell-
specific approaches. In this section, I propose different hypotheses that can explain how 
Aplp2 can regulate neural stem cell differentiation. Next, I take the example of APP gene 
family to discuss the advantages and disadvantages of the in utero electroporation 
approach. I end the discussion by explaining the discrepant observations on the different 
roles for App and Aplp2 in neuronal differentiation and migration and I will speculate on 
the future direction of research with regard to the physiological function of App proteins 
during cortical development.   
 
5.1 Hypotheses on Aplp2 regulation of neural stem cell differentiation  
 
We show that reduced levels of Aplp2 in App/Aplp1 dko progenitors leads to slower cell 
cycle exit and preservation of progenitors in their proliferative stage (Fig. 19). Aplp2 is a 
transmembrane protein with a large extracellular multidomain region and an intracellular 
domain and thus could regulate the proliferation of progenitors functioning either as a 
receptor, a cell adhesion molecule or a signal transducer. The intracellular YENPTY 
domain of Aplp2 can bind to several adapter molecules which are involved in the control 
of neurogenesis such as Dab1 (Homayouni, Rice et al. 1999; Lakomá, Garcia-Alonso et al. 
2011), Numb (Roncarati, Šestan et al. 2002) and Fe65 (Ma, Futagawa et al. 2008). Numb 
could regulate the decision to stop proliferation and promote differentiation as it represses 
Notch activity  (Roncarati, Šestan et al. 2002). Active Notch is promoting the self-renewal 
of radial glia progenitors (Yoon, Nery et al. 2004), the population which is also increased 
after Aplp2 down-regulation in progenitors of dko mice(Figs. 3F, 4D). Therefore, one can 
hypothesize that Aplp2 promotes the neuronal differentiation by directly or indirectly 
relaxing Notch activity.  
Aplp2 might regulate the neural stem cell proliferation by interacting with components of 
the cell cycle. Interestingly, the conformation and thus binding properties of the Aplp2 
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YENPTY interaction domain can be influenced by phosphorylation of Thr
668 
by a Cdk1 
kinase which couples Aplp2 function and metabolism to the cell cycle (Suzuki, Ando et al. 
1997). Similar to Aplp2, Cdk1 expression is also concentrated in the VZ/SVZ of the 
developing cortex (Visel, Thaller et al. 2004; Diez-Roux, Banfi et al. 2011) suggesting that 
Cdk1 could be involved in the regulation of neuronal development through Aplp2. 
Supporting a signalling role for Aplp2 in cell cycle, an analysis of proteins interacting with 
Aplp2, and not App and Aplp1, revealed members of RhoGTPase such as Rac1 and RhoA 
(Bai, Markham et al. 2008), which can potentially influence cell cycle progression (Vidaki, 
Tivodar et al. 2012; Yang, Wang et al. 2012). Moreover, a recent DNA microarray 
transcriptome profiling of the adult prefrontal cortex showed that the expression of genes 
involved in neurogenesis is altered in Aplp2 ko brains (Aydin, Filippov et al. 2011). In this 
study one interesting candidate was Cdk inhibitor p21 which was down-regulated in Aplp2 
ko mice. p21 down-regulation was found to enhance progenitor proliferation in the adult 
hippocampus (Pechnick, Zonis et al. 2008). More recently, it was shown that p21 
negatively regulates the expression of Sox2, a key regulator of neural stem cell 
proliferation (Marqués-Torrejón, Porlan et al. 2013). These data can link Aplp2 to 
components of cell cycle and it will be interesting to determine whether similar 
mechanisms are relevant for embryonic neurogenesis regulation.  
Finally, Aplp2 can influence cell cycle progression by regulating cell-cell and cell-
extracellular matrix interactions (Soba, Eggert et al. 2005; Müller and Zheng 2012) could 
directly regulate the decision between progenitor proliferation and differentiation into 
neurons, which is strongly dependent on specific membrane associated factors (Temple and 
Davis 1994). Indeed at the neuromuscular junction, APP family proteins are proposed as 
novel synaptic adhesion molecules (Wang, Wang et al. 2009) and it will be of interest to 
investigate a similar role in the context of neuronal progenitor differentiation.  
 
5.2 In utero electroporation to study neurodevelopmental processes: the 
example of APP proteins   
 
Previously, we approached the function of APP protein family by using in vitro 
differentiation of mouse embryonic stem cells. With this approach, we managed to analyse 
sufficient numbers of App triple ko neurons and neuronal progenitors in vitro. We did not 
find, however, any phenotype in triple ko neurons produced in vitro. This prompted us to 
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further analyse the role of App proteins in vivo by generation of chimeric mice using the 
morula aggregation technique. We succeeded in generating chimeric brains where triple ko 
neurons were randomly integrated into the wt brain. This technique allowed us to study 
triple ko neurons in the brain while avoiding lethality of the full triple ko mice. 
Nevertheless, the yield of the technique was not high. In fact, we obtained only 2 mice with 
brain chimerism, even though we used more than 1200 morulas in over 30 different 
experiments (Bergmans, Shariati et al. 2010). In contrast, in this study we used in utero 
electroporation to down-regulate Aplp2 in neurons and neuronal progenitors with a high 
yield. In our hands, more than 60% of embryos survived the operation and expressed the 
reporter gene in the brain. Using in utero electroporation, we circumvented the lethality of 
the triple ko mice by down-regulating Aplp2 in a subpopulation of cells in the ventral 
telencephalon (Fig. 8A). The cells are indeed viable under those conditions as shown by 
their even increased proliferation rate and their normal morphology (Figs. 10, 11,12). In 
addition, we performed the experiment in both WT and App/Aplp1 dko mice which 
provided us with a system to study "triple ko" neurons and neuronal precursors. Although 
our studies demonstrate that Aplp2 down-regulation alone is not sufficient to elicit 
developmental defects (Fig. 7A,B), the expression pattern of Aplp2 suggests a central role 
in neurogenesis; Aplp2 is specifically distributed in the proliferative VZ and SVZ of the 
developing cortex. In contrast, Aplp1 is restricted to the CP where differentiated neurons 
reside while App is distributed in both VZ/SVZ and CP (López-Sánchez, Müller et al. 
2005). Thus, App residing in the VZ/SVZ could be responsible for a compensating effect 
on proliferation in the single Aplp2KO mice. 
 
In utero electroporation is applicable in studies in which the cell autonomous functions of 
proteins are investigated. This technique allows studying the effect of genetic manipulation 
of cells in the subpopulation of cells in the wt brains. It is difficult to evaluate exactly the 
electroporation efficiency but we estimate that in our hand 5-10% of the cells in the 
targeted region were EGFP positive (after conservative dissection of the targeted region 
under the dissection microscope). This mosaicism allows to compare transfected cells with 
the neighbourhood cells that are unaffected and thus to investigate the cell-autonomous 
function of Aplp2. However, we cannot exclude the possibility of missing some 
phenotypes that are regulated by soluble fragments of Aplp2. One should also consider the 
possibility of non-autonomous effects on the cells that are not electroporated.  
  
We could also approach the cell-specific function of App and Aplps by combining in utero 
electroporation with a microRNA based system for shRNA expression. This combination 
allowed us to narrow down the function of Aplp2 specifically to neural stem cells. 
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Nevertheless, it should be taken into account that the choice of microRNA is critical for the 
functionality of shRNA. For example, in our hands the commonly used miR-30 scaffold 
did not work efficiently in the developing cortex. In fact, it has been shown that down-
regulation efficiency by miR-30 varies among different cell types (Liu, Xu et al. 2010). 
This might be due to the variability in the post-transcriptional processing of precursor 
transcripts of microRNAs. We chose Let7F scaffold for two reasons: First, it is enriched in 
the developing cortex; second, it is naturally expressed from an intron. We embedded the 
Let7F in a synthetic intron to avoid interfering with untranslated regions of the transcripts 
which are important for translation efficiency and stability of the transcripts.  
 
We used in utero electroporation to target the dorso-medial part of the developing cortex. 
Other groups have targeted other regions of the brains such as the prefrontal cortex or the 
ganglionic eminence to study tangential migration of inhibitory neurons (LoTurco, Manent 
et al. 2009). This can be done by changing the position of electrodes. In our experience, 
however, the precise control of which region is targeted was difficult because movements 
of the embryos during electroporation. Therefore, a high level of technical proficiency is 
required to spatially target different regions of the developing brain reproducibly. It is also 
reported that the long term effect of genetic manipulation by in utero electroporation can 
be studied postnatally. Two technical notes should be mentioned on the application of in 
utero electroporation for long-term analysis of the effect of genetic manipulation. First, the 
survival of the newborn mice depends on the maternal instinct of the mice which varies 
from strain to strain. Cross-fostering, gentle handling of the animals and a quiet mice room 
can improve the survival of the newborn pups. Second, the developmental activity of the 
DNA construct may decrease during the maturation of the neurons. The choice of promoter 
is one of the primary factors that need to be considered when designing long-term 
experiments.   
 
5.3 Controversies on the role of APP proteins in cortical development  
 
To our surprise, we did not observe migration phenotypes in App/Aplp1 dko neurons nor 
did we detect a migration phenotype in neurons expressing Aplp2 shRNA or  ―triple ko‖ 
neurons. This was consistent with our previous findings using triple ko neurons derived 
from ES cells (Bergmans, Shariati et al. 2010). In fact, our study had shown that Aplps and 
App appeared largely dispensable for the radial migration of cortical excitatory neurons. 
Cortical neuron positioning in App/Aplp1 double knock-out mice or in APLP2 knock-down 
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cells was indistinguishable from that in wt mice (Fig. 7A,B). Using in vitro assays, we 
showed that Aplp2 down-regulation does not change migratory behaviour of neurons (Fig. 
10). The absence of a migration defect contrasts with other findings showing abnormalities 
in neuronal migration during cortical development. Yet, the findings of these previous 
studies were not conclusive, one study showing a complete inhibition of cortical plate entry 
and the other an ectopic accumulation of neurons in the marginal zone (Herms, Anliker et 
al. 2004; Young-Pearse, Bai et al. 2007). 
However this delay in cortical neuron progression towards the CP is likely a consequence 
of a primary defect in progenitor function: First, we could not detect any differences in 
migration speed of isolated ―triple ko‖ neurons and wt neurons using an in vitro assay (Fig. 
10 A,B); second, we could phenocopy the accumulation of cells close to the VZ/SVZ by 
expressing Aplp2 shRNA only in progenitors of dko mice (Fig. 16 A,B). Indeed the effect 
of APP proteins on progenitor function could be a possible alternative or additional 
explanation for the observed cortical positioning defects in previous publications. This 
provides an interpretation that is different from what was proposed in the previous papers 
which considered migration defects as the primary cause. It should be noticed that those 
previous studies did not directly study migration. Timelapse microscopy could give insight 
in this particular question. With regard to these discrepancies, one should also consider that 
acute down-regulation of APP in a wt background may not have the same outcome as a 
germline deletion of APP which can trigger early developmental adaption.  
Taken together, the current data support a model in which App is functional in both 
progenitors and post-mitotic migrating neurons, whilst Aplp2 is playing a specific role in 
regulating progenitor proliferation and differentiation. 
 
5.4 Perspective on biological function of APP protein family during 
cortical development.  
 
The current findings indicate that App and Aplps are essential for correct completion of 
neurodevelopmental processes such as differentiation, migration, synaptogenesis and 
circuit formation. One of the first essential decisions for proper formation of the cortex is 
the exit from the cell cycle and the differentiation into postmitotic neurons. In fact, the 
prospective identity of a neuron is determined when its progenitor undergoes the last 
mitosis. The link between Aplp2 and cell cycle during cortical development opens avenues 
towards the understanding of new functions of App proteins during cortical development. 
However, the picture remains unclear. One remarkable question remains how Aplp2 
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signalling is integrated in the global signalling process and how it is responding to external 
cues that promote cell cycle progression and neuronal differentiation. It is possible that 
Aplp2 functions as a cell surface receptor responsible for the correct completion of the 
neurogenic program. Identification of the putative ligand would be possible by using cross-
linking and proteomics approaches. Along the same line, in vitro culture of neural stem 
cells is a valuable strategy to test the function of soluble signalling factors that promotes 
neuronal differentiation after down-regulation of Aplp2. Although this model presupposes 
a signalling role for Aplp2, one should not neglect the cell adhesion properties of Aplp2. 
Cell biological studies of Aplp2 subcellular localization and identification of the site of 
adhesion (apical or basal) are required to understand the link between the Aplp2 adhesion 
properties and cell cycle progression of cortical progenitors.   
It becomes clear that while investigating the biological function of App and Aplps, we lack 
deeper mechanistic insight. In this regard, defining the molecular interaction network of 
App and Aplps in different subregions and cell types of the developing cortex is of primary 
importance. It would be interesting to categorize shared and distinct interactors of App and 
Aplps. Sometimes APP is dubbed ―All Purpose Protein‖ to indicate the confusing many 
different signaling pathways and protein interactions in which APP has been implicated. 
Maybe this information has to be re-evaluated taking into account temporary and cell type 
expression patterns of APP family and the interacting proteins. It is indeed likely that App 
and Aplps rewire their interaction network according to the cell type to serve different 
functions. This will call attention to the cell specific function of App and Aplps. For 
example, the primary attention has been on understanding the neuronal function of App 
and Aplps. However, it is now clear that development of the circuits requires the 
interaction of neurons with each other as well as with glia. Until now, the function of App 
and Aplps in inhibitory neurons, astrocyte and microglia is not well-studied. Therefore, 
with the development of the conditional mouse models, it will become feasible to untangle 
cell specific functions of the APP protein family.   
Proposing App and Aplps as cell receptors may lead to a static view on their signaling role 
without considering their processing and its products. Although, we focused our studies on 
understanding the cell-autonomous functions of Aplp2, the regulated processing of Aplp2, 
and App, can mediate non-autonomous functions. This model hypothesizes the existence of 
a receptor for the soluble fragments of App and Aplps. Therefore, an effort in the field 
should also focus on the identification of the receptor for App and Aplps and the 
physiological importance of this interaction.   
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Finally, generation of specific inhibitor of enzymes involved in amyloidogenic processing 
of APP such as the BACE1 and γ-Secretase are viable approaches for treatment of 
Alzheimer‘s disease. Such compounds would ideally lower the Abeta burden without 
affecting processing of other substrates. No matter how challenging this might be, 
changing the metabolism of APP inevitably interferes with the physiological functions of 
APP raising the possibility of mechanism based side effects. At first glance, developmental 
functions of APP and APLPs appear a remote link to Alzheimer‘s disease. However, many 
neurodevelopmental processes continue to be active in the adult brain in processes such as 
adult neurogenesis. In fact, generation of neurons continues in two distinct neurogenic 
niches of the adult brain, i.e. in the subgranular zone of the hippocampus and the 
subventricular zone of lateral ventricles. Interestingly, hippocampus circuitry that is 
involved in memory formation is one of the primary regions affected in Alzheimer‘s 
disease. Whether and how APP proteins can contribute to generation of neurons in the 
adult brain and during aging remain unclear. Therefore, a clear understanding of the 
function of APP will be complementary to the pharmaceutical efforts to treat Alzheimer‘s 
disease.  
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